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ABSTRACT OF THE DISSERTATION
POSITRON EMISSION TOMOGRAPHY (PET) TUMOR SEGMENTATION
AND QUANTIFICATION: DEVELOPMENT OF NEW ALGORITHMS
by
Ruchir Bhatt
Florida International University, 2012
Miami, Florida
Professor Anthony McGoron, Major Professor
Tumor functional volume (FV) and its mean activity concentration (mAC) are the
quantities derived from positron emission tomography (PET). These quantities are used
for estimating radiation dose for a therapy, evaluating the progression of a disease and
also use it as a prognostic indicator for predicting outcome. PET images have low
resolution, high noise and affected by partial volume effect (PVE). Manually segmenting
each tumor is very cumbersome and very hard to reproduce. To solve the above problem
I developed an algorithm, called iterative deconvolution thresholding segmentation
(IDTS) algorithm; the algorithm segment the tumor, measures the FV, correct for the
PVE and calculates mAC. The algorithm corrects for the PVE without the need to
estimate camera’s point spread function (PSF); also does not require optimizing for a
specific camera. My algorithm was tested in physical phantom studies, where hollow
spheres (0.5-16 ml) were used to represent tumors with a homogeneous activity
distribution. It was also tested on irregular shaped tumors with a heterogeneous activity
profile which were acquired using physical and simulated phantom. The physical
phantom studies were performed with different signal to background ratios (SBR) and

iii

with different acquisition times (1-5 min). The algorithm was applied on ten clinical data
where the results were compared with manual segmentation and fixed percentage
thresholding method called T50 and T60 in which 50% and 60% of the maximum
intensity respectively is used as threshold. The average error in FV and mAC calculation
was 30% and -35% for 0.5 ml tumor. The average error FV and mAC calculation were
~5% for 16 ml tumor. The overall FV error was ~10% for heterogeneous tumors in
physical and simulated phantom data.

The FV and mAC error for clinical image

compared to manual segmentation was around -17% and 15% respectively. In summary
my algorithm has potential to be applied on data acquired from different cameras as its
not dependent on knowing the camera’s PSF. The algorithm can also improve dose
estimation and treatment planning.
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CHAPTER 1

Introduction
Liver cancer is one of the major causes of death due to cancer; it is the fifth most
common among men (13,980 deaths) and ninth most common among women (6,570 deaths),
with 21,370 and 7,350 new cases annually in men and women, respectively [1]. Radiation
therapy is one of the promising treatment methods for patients with unresectable 1 hepatocellular
carcinoma (HCC) 2. There are two main types of radiation therapy. The first is internal radiation
therapy, an example of whichis selective internal radiation therapy (SIRT). The second is
external radiation therapy, and examples of it are three-dimensional conformal radiation therapy
(3D-CRT), image modulated radiation therapy (IMRT) and image guided radiation therapy
(IGRT). The explanation of the different radiation therapies will be provided in the later section.

Liver tumor

Tumor necrosis

1

Tumors which cannot be surgically removed for variety of reasons which include size, location and the stage of the
tumors

2

Most common type of liver cancer

1

Figure 1.1 (left) a CT image of a patient with liver tumor, (right) PET/CT image of the same
patient but in this image necrotic core within the tumor is visible.
For all of the above mentioned radiation therapies, the most important starting point is
determining the accurate tumor volume and its contour 3. Tumor volume is used to determine the
dose for a particular therapy. Most of the radiation therapies use computed tomography (CT) for
calculating tumor volume because of the low cost compared to MRI and PET. CT and MRI give
only anatomical information of a tumor, whereas positron emission tomography (PET) provides
functional information. By providing functional information, PET is able to distinguish between
tissues which are metabolically active and which are necrotic. In Figure 1.1 (right) we can see a
PET/CT image with a liver tumor having necrotic core but in Figure 1.1 (left) CT image shows
liver tumor as a large uniform mass without the necrotic core. Using anatomical information
provided by the CT and MRI can sometimes lead to error in the dose estimation.
Utilizing tumor volume for dose measurement is just one application, another important
use of tumor volume is for prognostic value, i.e. for predicting the progression or outcome of a
tumor upon a treatment [2-9]. Keeping track of the tumor volume over the lifetime of the
treatment can lead to a better understanding of how effective a given treatment is for a given
tumor type.
Another important aspect of tumor quantification is estimating metabolic activity4 of the
tumor from PET. If a tumor shows more metabolic activity the chances of it being malignant is
much higher.

3

Location and the margins of a tumor

4

Amount of glucose uptake by a tumor

2

For a better comparison of metabolic activity between different patients or the same
patient at different times, the term standard uptake value (SUV) is widely used. SUV is the ratio
of the mean activity in a region of interest (ROI) times the body weight to the injected dose
(Equation 1.1). The mean activity in a ROI can also be called the mean activity concentration
(mAC) of tumors if the ROI includes only tumors. The ROI can include both tumors and organs
depending on what the SUV is being measured for. The quantity mAC 5 is dependent on the
functional volume 6 (FV). Another term that is used as a prognostic value is called total lesion
glycolysis (TLG), which is the product of FV and SUV [10-13]. From this definition we can see
that the accuracy of TLG is also dependent on tumor FV.
SUV =

Mean ROI concentration (Mbq / gm )
Injected dose (Mbq ) / Body weight ( gm )

(1.1)

One limitation of PET is that the resolution of a PET image is very low compared to CT
and MRI images. The low resolution of PET is due to the physics of the imaging modality
(positron range and scatter) and also due to the number of detector crystals on a camera’s gantry.
The PET images are also noisier compared to CT and MRI images; this noise is due to scatter
and low sensitivity of PET. There are many methods by which the noise in a PET image can be
reduced; one is by using the right kind of filter, but too much filtering can also reduce the
contrast; second is to use cameras having time of flight (TOF) capability, even though it is a very
promising method it is expensive and provides limited gain compared to a standard PET camera.
Another limitation of PET is that PET images suffer from partial volume effect (PVE).
PVE is equivalent to the convolution of the actual image with the camera’s point spread function
5

Mean activity is the ratio of sum of all the intensity values of pixels segmented as tumor times the number of
pixels segmented

6

It’s the metabolically active volume measured from PET

3

(PSF). The spatial resolution of the camera is equal to the full width half maximum (FWHM) of
the Gaussian PSF. The PSF is not spatially uniform, so retrieving the original image is an illposed problem [14]. In Figure 1.2 we observe that PVE makes the margins of the actual object
blurry, and this blur is what makes it difficult to quantify the tumor FV.
PVE affected
Object

Figure 1.2 we see the effect of partial volume effect (PVE) on an 2D object, where the size of the
measured object (right) is larger and activity is smaller than the actual object (left) (image
modified from Soret et al 2007) [15].
To date, manual segmentation is still considered the gold standard for segmenting a
tumor. The manual segmentation of tumors in PET images is time consuming, which can lead to
attrition on the part of radiologist, affecting the result. Additionally, the results from manual
segmentation are very hard to reproduce making it difficult to use if large sets of data are
required to be processed in the clinic. The importance of the tumor FV and the impracticality of
manual segmentation are two of the motivations behind developing an automatic tumor
segmentation and quantification algorithm for PET images.
Currently, there is no standard protocol in which PET images are reconstructed, as they
vary with different manufacturers. Each manufacturer of a PET camera uses slightly different
4

geometries, detectors size and reconstruction algorithms; this makes it imperative to develop an
algorithm which does not need to be optimized for a particular camera. I have developed iterative
deconvolution thresholding segmentation (IDTS) algorithm which is the combination of the
histogram thresholding and Van-Cittert deconvolution methods. The algorithm is unique as it
segments; measures FV, and also measures PVE corrected mAC. I have formulated the stopping
conditions within the algorithm in such a way that the algorithm does not need to be optimized
for a particular camera. This feature will enable the algorithm to be useful in analysis of multicenter PET data. The algorithm, as an initiation step, requires user input in generating a volume
of interest (VOI), after which the algorithm is automatic. Herein, the IDTS algorithm is tested on
a physical tumor phantom with homogeneous and heterogeneous activity, simulated phantom
data-NCAT phantom with added Gaussian blur and noise to mimic real data and clinical data
which is validated with comparison to manual segmentation by a radiologist.
1.0 ORGANISATION OF THE DISSERTATION
The dissertation is organized as follows and the flow of the dissertation is given in Figure 1.3:
Chapter: 1 gives Introduction and the description of different radiation therapies, SIRT, 3DCRT, IMRT and IGRT. The chapter also gives information on how the tumor FV is used to
calculate prescribed dose.
Chapter: 2 provides background on different segmentation and FV estimation algorithms and
how they vary from each other. And also gives information about different PVE correction
algorithms which are used to calculate corrected activity concentration.

5

Chapter: 3 mathematically describes the iterative deconvolution thresholding segmentation
(IDTS) algorithm. The chapter also contains information about alterations made to the IDTS
algorithm so that it can be successfully applied on clinical data.
Chapter: 4 describes the algorithm to generate volume of interest (VOI) from user drawn ROI.
Chapter: 5 provides results of estimated FV and mAC from physical phantoms with
homogeneous activity profile and on tumors with heterogeneous activity profile, generated
through physical phantom and simulated phantom studies. The chapter also provides the results
of the impact of tumor FV and mAC with the change in reconstruction algorithm parameters.
The chapter provides result of the IDTS algorithm when applied on clinical data. The result from
the IDTS algorithm and fixed percentage thresholding are compared to the manual segmentation
(gold standard). In this chapter we apply the altered IDTS on phantom data and compare the
variation in the results to the IDTS algorithm.
Chapter: 6 provides general discussion and significance of the work and also gives an outline of
possible future work.

6

Materials and
method

Introduction and
Background

Chapter 1: Introduction
Chapter 2.1: Background on segmentation and FV estimation
algorithms
Chapter 2.2: Background on PVE correction algorithms

Chapter 3: Iterative deconvolution thresholding segmentation
(IDTS) algorithm
Chapter 4: Volume of interest (VOI) generating algorithm

Results and discussion

Chapter 5.1: Result from physical phantom studies
(homogeneous tumors)
Chapter 5.2: Results from physical and simulated phantom
studies (heterogeneous tumors)
Chapter 5.3: Result of algorithm applied on clinical data

Conclusion and
future work

Chapter 5.4: Impact of variation in VOI on the FV

Chapter 6.1: Overall discussion and significance of the work
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1.1 RADIATION THERAPY
1.1.1 INTRODUCTION
Radiation therapy is a potential treatment for patients who have unrespectable hepatocellular
carcinoma. There are two types of radiation therapy: external radiation therapy and internal
radiotherapy. This chapter provides a brief description of the different radiation therapy methods
and how dose is calculated.
1.1.2 SELECTIVE INTERNAL RADIATION THERAPY
In selective internal radiation therapy (SIRT) a micro-particle is tagged with a beta
emitting radioisotope (e.g. Yattrium-90). The SIRT therapy is also termed as radioemboization
therapy. The SIRT treatment kills the tumor in two ways: 1) micro-particles are lodged and get
stuck in the tumor where they stop the supply of oxygen and thereby starve the tumor cells, 2)
the radioisotope which is tagged gives out beta radiation thereby killing the tumor cells. The
range of the beta emitter is not high so the normal tissues are spared from radiation. Figure 1.4
shows an illustration of how the particle gets lodged into the tumor through the arteries.

Y-90 microparticles

Catheter

Figure 1.4 Illustrated representation showing the particles injected inside a tumor.
There are two types of particle mostly used in the clinics Sir-spheres and TheraSphere.
Sir-spheres are micro resin particles and TheraSpheres are glass particles. This particle are
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tagged with yattrium-90 (Y-90) radioisotope and injected through the hepatic artery. There have
been many literature publications comparing the performance of the two spheres with equal
efficacy [16-19]. The dose for SIRT treatment has been mostly estimated using computed
tomography (CT) images [20-23]. PET has also been recently used for estimating dose and
where liver tumor volume and liver tumor contour are combined to estimate dose [24]. The
formulation of the dose calculation is given in the Equation 1.2 below
Dose(GBq) = BSA - 0.2

Volume tumor
Volume tumor − Volumeliver

1.2

where BSA is body surface area. The role of PET in the SIRT treatment has been steadily
increasing, not just for treatment planning, but also for prognostic evaluation [25-27]. Both
tumor volume and standard uptake value are used for prognostic evaluation [22, 25, 26].
1.1.3 EXTERNAL RADIATION THERAPY
There are many forms external radiation therapy, including the ones called three
dimensional conformal radiation therapy (3D-CRT). In this therapy a topographic image is take
like computed tomography (CT), magnetic resonance imaging (MRI) or positron emission
tomography (PET) to construct a 3D stereoscopic image and through computer software the
radiation beam is conformed around the tumor. Figure 1.5 gives an example of how an external
beam is applied on tumors in the abdomen.
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Gamma beam
different color
signifies different
energies

Figure 1.5 Conceptual illustration of how the external radiation therapy works, where different
colors represent different energy beams (Image modified from Hartgrink et al) [28]
The 3D-CRT only provides uniform intensity over the volume and the next evolution of
the treatment is called intensity modulated radiation therapy (IMRT). The IMRT differs from
3D-CRT such that IMRT uses a modulated radiation beam which can apply precise dose based
on the tissue type. IMRT treatment is mostly applied on head and neck tumors and the dose is
calculated using CT images. The dose applied is calculated by software based on the image; this
concept is called dose painting (Figure 1.6).

Figure 1.6 Dose painting. Different colors represent different amount dose given in centigray
(cGy). (Image modified from Hartgrink et al) [28].
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Recently PET images are used for head and neck tumor contour volume since CT images
cannot provide information if the region is necrotic or hypoxic. If the regions within the tumor
are hypoxic it requires higher dose than the rest of the tumor [29, 30].
The next evolution of the external radiation is called image guided radiation therapy
(IGRT) where the treatment is adapted based on the movement of the tumor. More than IMRT,
IGRT provides better treatment protocol when applied in the liver as the tumors in liver move
due to breathing.
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CHAPTER 2
Background

2.1 FUNCTIONAL VOLUME ESTIMATION ALGORITHM
2.1.1 INTRODUCTION
The functional volume (FV) estimation starts with tumor segmentation. There are many
algorithms which find FV directly or apply segmentation and FV estimation in two steps [31,
32]. The major kind of segmentation algorithms are adaptive thresholding, active contouring
(also termed as snakes), gradient based segmentation, clustering algorithm and fuzzy logic based
segmentation.
2.1.2 ADAPTIVE THRESHOLDING
Adaptive thresholding uses features from the image by fitting it to the actual volume. The
parameters are derived from the curve and used for segmentation [33-39]. The adaptive threshold
needs to be optimized for each camera as the fitting curve for one camera does not apply to other
cameras. The features are mostly found by doing phantom studies, which makes it difficult to
apply if any of the features changed from the phantom studies. It is difficult to fit a curve and
find parameters for all cases as the phantom data is very simple and cannot correlate well with a
clinical image.
2.1.3 ACTIVE CONTOUR SEGMENTAITON
The active contour method (also termed as snakes) finds the point of low energy around
the image [31, 40, 41]. The active contour algorithm requires a pre-stage, usually filtering or
thresholding, as the performance of the active contour method is very limited in PET images.
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This algorithm has very limited scope as it requires tumors that are well separated. Li et al. used
a region growing algorithm to segment all the tumors and then used an active contour method to
find the FV [31]. The algorithm requires input parameters which must be optimized by
performing phantom studies.
2.1.4 GRADIENT BASED SEGMENTATION
Gradient based segmentation uses a gradient or edge detection of tumor boundaries to
determine the tumor volume. Geets et al. used a watershed algorithm for segmenting tumors. The
algorithm is applied in two steps where the deconvolution is applied to make the boundaries
sharper. In PET images the boundaries of the tumor are very blurry and require some
enhancement. They tested the algorithm with phantom data with spherical tumors but only using
one signal to background ratio. The algorithm performed better in the clinical images but they
are difficult to validate.
2.1.5 CLUSTERING ALGORITHM
The clustering algorithm is the machine learning algorithm which iteratively isolates the
tumor from background. The algorithm uses fuzzy C-mean clustering which segment the pixels
based on their location with respect to each other in order to remove the blur. A wavelet
transform is used so that the algorithm could converge to the right volume [42]. Belhassen et al.
used NCAT simulated phantom only to validate their algorithm and did not perform any physical
phantom studies. The algorithm was able to segment tumors with heterogeneous activity profile
[42]. Yang et al. also tested their algorithm on simulated phantom data and were able to segment
heterogeneous tumors as well as the heterogeneity within the tumor [43].
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2.1.6 FUZZY BASED SEGMENTATION
Fuzzy based segmentation uses fuzzy logic where the stochastic statistics are used to
determine if a pixel belongs to the tumor or background [44]. Hatt et al. have developed a fuzzy
logic based Bayesian segmentation algorithm. The algorithm is computationally expansive as it
has to determine for each pixels if it belongs to background or tumor. The algorithm was tested
on physical phantom data and also on simulated phantom data. The algorithm failed to segment
tumors less than 1 ml in volume. The algorithm was later modified to make it able to segment
heterogeneous region within the tumor [45].
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2.2 PVE CORRECTION ALGORITHM
2.2.1 INTRODUCTION
Partial volume effect (PVE) is the major hurdle in the quantification of the tumors
activity. The activity of the tumor is used to determine if the tumor is malignant or benign. The
partial volume effect can make malignant tumor look benign [15]. There have been many
methods of PVE correction but not all methods are applied for tumor quantification. One of the
major applications of PVE correction is in brain studies [46]. The brain is a compact organ where
activity from the desired sites spill out into neighboring regions. Algorithms used for PVE
correction in the brain are beyond the scope of the research. The PVE correction algorithm
changes from its application. PVE correction can be applied to quantify tumors or it can be
applied to measure the volume of a compartment in kinetic studies [47]. There are two major
methods of PVE correction; one uses anatomical data like computed tomography (CT) and
magnetic resonance imaging (MRI) and another method uses deconvolution to correct for PVE.

2.2.2 ANATOMICAL DATA BASED PARTIAL VOLUME EFFECT CORRECTION
In this method the anatomical information provides the margin around the tumor and by
blurring with the resolution of the camera and then subtracting and dividing with PET data we
get the PVE corrected activity [48]. The problem with this method is that it requires coregistration of anatomical data with the PET data for the PVE correction to be successful. This
can be challenging if the patient moved during any of the scans.
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2.2.3 DECONVOLUTION BASED PARTIAL VOLUME EFFECT CORRECTION
The deconvolution method involves deconvolving the image with the point spread
function (PSF) of the camera. Finding the right value of the PSF can be challenging as the PSF is
not spatially uniform. Using a single value PSF in the deconvolution algorithm is not optimal for
PVE correction. Moreover the deconvolution process adds noise within the image, and this noise
can be controlled by adding a regularization term to the deconvolution algorithm [49]. Kirov et
al. used the deconvolution method with regularization. The PSF they employed was not the
cameras PSF but was custom made for their algorithm [49]. The PVE correction method only
corrects the maximum intensity pixel and the mean value is not corrected. Teo et al. used VanCittert deconvolution but employed a slightly larger PSF function than the camera’s [50]. On the
other hand, Barbee et al. used spatially varying PSF which was acquired through phantom
studies [14]. Boussion et al. used the Lucy-Richardson deconvolution method with wavelet
transform [51]. They performed PVE correction on the entire image rather than on a single
object.
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CHAPTER 3
Tumor Segmentation and Quantification Algorithm

3.1 INTRODUCTION
The whole tumor quantification algorithm is divided into four parts. The first part of the
algorithm is called histogram thresholding (HT) where the tumor and the blur around the margins
(due to PVE) of the tumor are segmented. The blur is included in order to measure the total
activity of the tumor, since part of the activity from the tumor spills out to the background. The
second part is called iterative deconvolution thresholding segmentation (IDTS), where the output
from the HT algorithm is inputted and the blur around the tumor is segmented to derive FV. The
third part of the algorithm is the stopping conditions; these stopping conditions enable the
algorithm to be independent of the camera’s PSF. The fourth and final part of the algorithm is
called maximum intensity correction (MIC). An outline of the complete algorithm is shown in
Figure 3.1. The second part of the method, the IDTS algorithm, utilizes a combination of
deconvolution and the modified histogram thresholding (MHT) algorithm iteratively until the
stopping condition is reached. The output of the IDTS algorithm is checked for volume. If the
volume is <1.8 ml it is subjected to maximum intensity correction (MIC), which is shown in
more detail in Figure 3.4 and will be discussed in a later section. The FV derived from the IDTS
algorithm and the total activity from the HT algorithm is used in estimating the AC of the tumor.

17

Figure 3.1 The complete outline of the tumor quantification algorithm.
The algorithm described in this paper was applied in two dimensions (2D) on each slice
individually over the entire volume. Experimentally it was observed that the algorithm failed to
segment small tumors (< 1ml) when applied in three dimensions (3D). To avoid segmentation of
local maxima due to the application of the algorithm in 2D, it was once applied on the transaxial
plane and once on the sagittal plane and the intersection of the two volumes was considered as
the FV. The variables considered in the paper are 3D functions of coordinates (x,y,z); however,
since operations are performed slice by slice, they will be written as 2D functions of (x,y) with a
subscript z parameterizing the slice coordinate. The above formalism is correct for transaxial
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operations; for sagittal, x is substituted for z to obtain 2D functions of coordinates (z,y) at
different x slices.
3.2 HISTOGRAM THRESHOLDING ALGORITHM
The PET image does not produce a bipeak (bimodal) histogram because of the huge
intensity variation between tumor and background. This makes it impossible to find the point of
maximum variance for the identification of optimal threshold, which would segment the tumor
from the background. To overcome this limitation, a HT algorithm was developed which
iteratively finds the optimal threshold. In Figure 3.2, the flow chart and different stages of the
HT algorithm are shown. The HT algorithm is initialized by inputting the manually drawn ROI
and ROI subtracted image called background (BK). The HT algorithm gives out the segmented
tumor (SG) after k iterations, and the value of k = {0,1,2,..,k}. The HT algorithm works by
k
iteratively finding the point of intersection between the histograms of background H BK
(T ) and
k
the segment H SG
(T ) . T is the bin value, where Q = {0,1,.., P } is the bin number and P is the

total number of bins. The value of each bin is given by T(Q)=(max( I ( x, y, z ) )/ P ) × Q, where '× '
is the multiplication operator. In both the histograms, the initial 10 bins are discarded since they
primarily contain the pixels outside the phantom (or outside the body for clinical images), where
the intensity is as much as 100 times lower than the intensity in the phantom. The histogram was
divided into 256 bins, since increasing the number of bins made the histogram noisy and
reducing the bin number below 256 can lead to sampling error where a wide range of intensities
can be assigned to a single bin. For the initial segment in the HT algorithm the observer has to
draw a 3D ROI around a tumor (Figure 3.2.b) in image I(x,y,z) (Figure 3.2.a), where x, y and z
indicate the 3D coordinate space and x = {1,2, ..,X}, y = {1, 2, ..,Y} and z = {1, 2, ..,Z} indicate
the size of each dimension.
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Figure 3.2 Block diagram of the HT algorithm with different components. (a) The original image
on which the observer would draw a ROI. (b) Manually drawn ROI encompassing the selected
tumor. (c) Initial segment (SG) and background (BK) obtained from the ROI. (d) Histogram of
the background and the SG are plotted on the same scale and Tzk is the threshold calculated
between bins T1 and T2. (e) Once the stopping condition is satisfied the SG derived includes the
blur around the tumor.
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After attaining the subsequent binary mask by drawing the 3D ROI (called ‘ROI’), the initial
value of SG and BK for k = 0 is defined as

SGz0 ( x, y ) = I z ( x, y ) • ROI z ( x, y ) and

BK z0 ( x, y ) = I z ( x, y ) − SGz0 ( x, y ) , respectively (Figure 3.2.c), and '•' is the point wise
multiplication.
The HT algorithm utilizes the histogram of SGz ( x, y ) and BK z ( x, y ) (Figure 3.2.d) to iteratively
find the threshold value ( Tzk ) in the range between T1 and T2 (Equation 3.1). T1 is the bin value,
k
the value where H BK
(T ) is maximum and T2 is the bin value of the last bin ‘P’ (Equation 3.1).

The threshold is the point of intersection between the two histograms and Equations 3.1 and 3.2
shows how the value Tzk is calculated. As the algorithm is applied in 2D, Tzk is calculated for
each slice (z).
k
k
k
k
min({T : H BK
(T ) ≤ H SG
(T )}) if max( H BK
(T )) ≥ max( H SG
(T ))

k
k
k
k
k
Tz = min({T : H BK (T ) ≥ H SG (T )}) if max( H BK (T )) ≤ max( H SG (T ))
0
Otherwise


(3.1)

Tzk ∈[T1 T2 ]; Where T1 = {T : max{H k BK (T )} and T2 = T ( P)

(3.2)

The Tzk value achieved from Equations 3.1 and 3.2 is used to update BK zk ( x, y ) and

SGzk ( x, y ) as described in Equations 3.3 and 3.4.
BK zk ( x, y ) = I z ( x, y ) − SGzk ( x, y )
SG

k +1
z

 I ( x, y )
( x, y ) =  z
0

if

(3.3)

SGzk ( x, y ) ≥ Tzk
Otherwise

21

(3.4)

The algorithm is continued until the stopping condition Tzk +1 = Tzk is satisfied. Once the
stopping condition is satisfied the segmented tumor (SGk) (Figure 3.2.e) achieved is not corrected
for PVE and contains the blur pixels around the tumor.
In the case of multiple tumors in a homogeneous background the HT algorithm can be
applied on all tumors simultaneously. Due to the inherent noisy nature of the PET image, the HT
algorithm segments isolated small regions as tumors. These regions are just two dimensional
noise regions and, based on their dimensionality, these noise regions are removed. The image
derived after removal of the noise region is converted into a binary image BI according to
Equation 3.5 (below).
1
BI ( x, y , z ) = 
0

if

SG ( x, y , z ) > 0
Otherwise

(3.5)

3.3 THE IDTS ALGORITHM
The SG and BI from the HT algorithm are now inputted to the second stage of the algorithm
(in Figure 3.1 box called IDTS algorithm). The IDTS algorithm (after satisfaction of the stopping
condition) outputs TU, where TU is the binary mask of the PVE corrected segmented tumor. TU
is further used to calculate FV. The IDTS algorithm is a combination of two parts, deconvolution
and the MHT algorithm. The IDTS algorithm is applied on each tumor individually. Henceforth
the explanation of the algorithm is for finding the FV for a single tumor. The IDTS algorithm is
the prime algorithm which corrects for the PVE, and the value of the TU is dependent on the
stopping conditions. The purpose of the stopping conditions is to automatically terminate the
algorithm making it independent from arbitrarily choosing the number of iterations. A detailed
explanation of the stopping conditions is given in section 3.4.
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3.3.1 DECONVOLUTION METHOD
PET images are always blurred by the camera’s PSF, and deconvolution is often used to
deblur the image. For accurate recovery of a non-blurred image, it is necessary to accurately
estimate the PSF of the camera, which is quite challenging if the PSF is non-isotropic. The
proposed algorithm uses the Van-Cittert’s deconvolution method (Equation 3.6 below). In
Equation 3.6,

α is the convergence parameter which is set to value 1 and '⊗' is the convolution

operator.

DE zk +1 ( x, y ) = DE zk ( x, y ) + α ( I z ( x, y ) − PSF ⊗ DE zk ( x, y ))

(3.6)

Where, DE zk +1 ( x, y ) ≥ 0 and DE z0 ( x, y ) = I z ( x, y )
PSF is the 2D Gaussian point spread function and DE zk ( x, y ) is the deconvolved image.

DS zk ( x, y ) is the segment of a deconvolved image (given in Equation 3.7 below), which is used
in MHT algorithm.

DS zk ( x, y ) = DE zk +1 ( x, y ) • BI z ( x, y )

(3.7)

To obtain TU zk ( x, y ) , the deconvolution algorithm is used at the onset to aid the MHT
algorithm in segmentation of the blur around the tumor. The number of iterations (k) required to
obtain TU zk ( x, y ) is dependent on the amount of blur present and the choice of PSF used in
Equation 3.6.
3.3.2 MODIFIED HISTOGRAM THRESHOLDING (MHT) ALGORITHM
The MHT algorithm used is similar to the HT algorithm, where instead of SGzk ( x, y ) ,
k
DS zk ( x, y ) is used to generate H SG
(T ) . Unlike the HT algorithm, the value of T(P) keeps
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updating with every iteration ‘k’. The value of each bin is T (Q) = (max(DS k / P)) × Q . The
BK z ( x, y ) is kept constant when applying the MHT algorithm (Equation 3.8). The histogram
k
(T ) and H BK (T ) , respectively, is inputted in
derived from DS zk ( x, y ) and BK z ( x, y ) , H SG

Equations 3.2 and 3.3 to obtain the threshold ( Tzk ).

BK z ( x, y ) = I z ( x, y ) − SGz ( x, y )

(3.8)

The background is not updated since now we are segmenting blur from the SGzk ( x, y ) , and
the intensity of the blur is found to be mostly greater than the intensity of the background. When
the tumor has heterogeneous activity distribution there is a possibility that the intensity of the
blur on the edges could be greater than the intensity of some pixels within the tumor. So making
the blur pixels part of the background can lead to segmentation of those pixels within the tumor.
The DS zk ( x, y ) and Tzk are used to derive a binary image TU zk ( x, y ) , as given in Equation
3.9. TU zk ( x, y ) includes the tumor whose blur is segmented.

1
TU ( x, y ) = 
0
k
z

if

DS zk ( x, y ) ≥ Tzk

(3.9)

Otherwise

VOzk is the total number of voxels calculated from TU zk ( x, y ) (Equation 3.10), and the
product of total VOz and volume of each voxel provides the FV (Equation 3.11) of a tumor,
VO zk =

X ,Y

∑ TU

x , y =1

k
z

(3.10)

( x, y ) ,

Z

FV = ∑VO z × Volume of a voxel .

(3.11)

z =1
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3.4 STOPPING CONDITION
The main challenge in the development of this algorithm was in determining the most
appropriate stopping condition which could lead to accurate volume estimations. As a result, two
stopping conditions were deemed necessary: one that is applicable to tumors of all sizes having
homogeneous activity uptake and another that is applicable when the size of the tumors is large
(>8ml) and on tumors with heterogeneous activity uptake. The IDTS algorithm does not
determine the applicability of the specific stopping condition depending on the nature of the
tumor, and the algorithm is terminated when either one of the two stopping conditions is
satisfied.
3.4.1 FIRST STOPPING CONDITION
In an ideal image which is not affected by blur and noise, the activity concentration (AC)
is close to the maximum intensity for an object. For large tumors in PET images, the maximum
intensity is close to the actual AC.
The value of maximum intensity (MV) of SG (Equation 3.12 below) reduces as the size of the
tumor decreases due to PVE. The MV of a tumor is still the value that is least affected by PVE.

MV = max( SG ( x, y , z ))

(3.12)

Due to the application of the whole algorithm in 2D the algorithm calculates AC
(Equation 3.13 below) of tumor on each slice (z) and compares it with MV. The first stopping
condition is induced when AC is greater than or equal to MV (Equation 3.14 below); this
condition is checked for each iteration (k) and each slice (z). It is important to remember that the
first stopping condition is applicable on tumors with homogeneous activity uptake,
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X ,Y ,Z
k
z

AC =

∑ SG( x, y, z )

x , y , z =1

(3.13)

VOzk

AC kz ≥ MV

(3.14)

3.4.2 SECOND STOPPING CONDITION
The second stopping condition is based on the nature of the deconvolution algorithm. It is
most useful in segmenting tumors with heterogeneous activity uptake. The outcome of the
deconvolution process is different for tumors whose volume is <8ml in comparison to tumors
whose volume is ≥ 8ml. In Figure 3.3 (below) the value DS zk ( x, y ) increases from the center
and decreases towards the edges, whereas in Figure 3.3.b (below) the value of DS zk ( x, y ) tends to
zero at the center as well as towards the edges. It should be noted that the value of DS zk ( x, y )
approaches zero towards the edges regardless of the size of the tumor.
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Figure 3.3 The deconvolution applied on the line signal (solid line) from a 4 ml tumor (a) and 16
ml tumor (b) after 8 iterations. DS (dotted line) is the segmented deconvolved signal. (a) The
value of DS increases from the center and approaches zero at the edge. (b) The value of DS
approaches zero at the center and the edge.
This information should be considered to avoid segmentation of pixels from the central
part of the tumor. The tendency of the value of DS zk ( x, y ) to go to zero at the center for large
and heterogeneous tumors is used to formulate the second stopping condition. The second
stopping condition is actuated when a value of DS zk ( x, y ) at the center goes below the threshold
( Tzk ) gained from the MHT algorithm, at which point the IDTS algorithm is terminated. For
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tumors with heterogeneous uptake, the second stopping condition is usually reached at a lower
number of iterations compared to the first stopping condition. This property helps the algorithm
from over or under estimating the FV. For the identification of the pixels belonging to the center
region of DS zk ( x, y ) , a morphological operation of erosion is used.
3.5. MAXIMUM INTENSITY CORRECTION
At this stage of the process, the IDTS algorithm will return an overestimated FV for small
tumors but a more accurately estimated FV for large tumors. The overestimation of FV hampers
the performance of AC estimation as it is a function of FV (Equations 3.11 and 3.13). In order to
get FV closer to the actual volume, it is necessary to compensate for the reduction of maximum
intensity due to PVE, especially in small tumors (<1.8ml). Hence, it is necessary to develop a
method by which a correction for the maximum intensity value (MV) is possible. The main idea
of MIC is to iteratively segment the blur pixels from SG and add the mean value of the blur
pixels (MBV) to the MV. The algorithm is iteratively progressed until it arrives at the updated
maximum value (uMV). In Figure 3.4 (below), the MIC algorithm is implemented outside the
original IDTS algorithm hence we use a different variable for the iteration number ‘j’. The
variable with index ‘j’ would be identified as a variable derived from the MIC algorithm and
value of j = {0,1,2..,j}.
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Figure 3.4 Complete block diagram of maximum intensity correction (MIC) algorithm. The
output from the MIC is used as the stopping condition in the main IDTS algorithm.

After calculation of uMV j , the IDTS algorithm will be re-applied and FV would be recalculated for a tumor. During the re-application of the IDTS algorithm the uMV

j

would be

used in the first stopping condition instead of MV (Equation 3.14). The MIC is only applied once
on a tumor and an outline of the algorithm is shown in Figure 3.1.
It is observed from experiments that the greatest overestimation of FV occurred for
FV<1.8ml. Therefore, 1.8 ml was chosen as a threshold to determine which tumor should be
subjected to the MIC algorithm. The MIC algorithm is a combination of IDTS algorithm and
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stopping condition applied on one slice of SG, where ‘N’ is the slice number. The goal of the
MIC algorithm is to calculate uMV j , so the slice which contains the MV pixel (the number of
that slice is ‘N’) is selected to be subjected to the MIC algorithm. We choose one slice in the
MIC algorithm because applying MIC in the whole 3D tumor leads to an overestimation of
maximum intensity, which in turn leads to an underestimation of FV.
After identification of the qualified tumors for the MIC algorithm, the parameters SG
and the binary image BI gained from HT algorithm are inputted into MIC algorithm. Once the
slice number N is identified from SG, SGN ( x, y ) and BI N ( x, y ) are subjected to the IDTS
algorithm (within the MIC algorithm) until the stopping conditions are satisfied. Next TU Nj ( x, y )
and VONj are derived from the above step and used to identify the spill-out or blur pixels which
in turn would be used to measure mean value of blur pixels (MBV). From Equation 3.15 below,
the BR j ( x, y ) is the binary 2D image displaying the location of the blur pixels.

BR j ( x, y ) = BI N ( x, y ) − TU Nj ( x, y )

(3.15)

The BR j ( x, y ) would be used to measure the MBV j ;however, for small tumors the spill-in is
significant and must be accounted for. This is achieved by measuring the mean background (MB)
through application of dilation operation around BI N ( x, y ) as expressed in the following
equation.

DL ( x, y ) = ( BI N ( x, y ) ⊕ ST ( x, y )) − BI N ( x, y )

(3.16)

DL( x, y ) contains all of the pixels that are outside of BI N ( x, y ) after application of the

morphological operation of dilation (Equation 3.16), designated by the symbol ‘⊕’. ST ( x, y ) is
the structuring element, which in this case is a unitary matrix of size 3 × 3. The dilation operation
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is used to estimate MB because the pixels around the blur are most responsible for spill-in. The
dilation for such a small tumor is chosen to be safe as there is less chance of including the
intensity of neighboring tumors in the calculation of MB. In Figure 3.4, it is shown that MB is
calculated only once at the start.
DL( x, y ) measured from Equation 3.16 and I N ( x, y ) (where, I N ( x, y ) is a 2D image of the

original input data (I(x,y,z) )) is used in the measurement of MB (Equation 3.17).
X ,Y

MB =

∑ ( DL( x, y) • I

x , y =1

N

( x, y ))

(3.17)

X ,Y

∑ DL( x, y)

x , y =1

Furthermore, MB would be used to measure MBV

j

(Equation 3.18 below). MB is used in

MBV j measurement because with small sized tumors with low SBR (<5) the effect of spill-in is

strong and the intensity of blur pixels is highly influenced by the intensity of the background. If
the SBR is high, Equation 3.19 (given below) can be used instead to yield better results.
Identifying the true SBR in any clinical image presents a challenge, thus the algorithm becomes
impractical if it is dependent on the SBR. Hence, Equation 3.18 is used in the proposed
algorithm in order to make this algorithm applicable under any condition.
X ,Y

j

MBV =

∑ ( BR

x , y =1

MBV =

( x, y ) • SGN ( x, y )) − ( MB ×

X ,Y

∑ BR

x , y =1

VONj
X ,Y

j

j

∑ ( BR

x , y =1

j

j

( x, y ))

(3.18)

( x, y ) • SGN ( x, y ))

(3.19)

VONj
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The MBV j gained from Equation 3.18 or Equation 3.19 is used to calculate uMV

j

(Equation 3.20) and the uMV j is be inputted in the stopping condition as shown in Figure 3.4.
The algorithm continues till the condition uMV

j +1

= uMV j is satisfied, then the uMV is injected

in the stopping condition of the main algorithm (Figures 3.1 and 3. 4).

uMV j = MV + MBV

j

(3.20)
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3.6. ALTERED HISTOGRAM THRESHOLDING (FOR CLINICAL IMAGES)
The HT algorithm, when applied on some clinical images, fails to find the correct
threshold and thereby fails to segment the tumor. The clinical images, unlike phantom images,
have high heterogeneous activity profile in the background; this causes the histogram to be
noisy. The noisy histogram is the main reason why the HT algorithm fails The noisy histogram
affects the HT algorithmbecause it uses Equations 3.1 and 3.2 to find the threshold, where the
k
threshold is the point of intersection between the histogram of the background ( H BK
(T )) and the
k
histogram of the segment ( H SG
(T )) , where T is the bin value. With threshold (Tk) at every

iteration k, the algorithm updates the background image (BK) and segment image (SG), given in
Equations 3.3 and 3.4.
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Figure 3.5 The progression of HT algorithm after (a) iteration 1, (b) iteration 5 and (c) iteration
30.
Figure 3.5 shows histograms of BK and SG after the application of HT algorithm at
iterations 1, 5 and 30. The threshold fails to moves forward after 5 iterations and its value
remains the same after 30 iterations. In Figure 3.5 we see that there are many bins still
overlapping on each other. This is the feature which shows that the HT algorithm has failed. The
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overlapping features of the histograms were similar for all clinical cases on which the algorithm
was applied and failed. Hence, the overlapping feature was used to solve the failing of the HT
algorithm in the clinical image by altering the method for calculating the threshold. In the
original HT algorithm, the algorithm was stopped when the threshold (Tk) equals Tk-1 with Tk the
final threshold after k iterations. From section 3.2 we know that T is the bin value, Q is the bin
number {0,1,2,..,P} and P is the total number of bins. We also showed how bin value (T) is the
function of bin number (Q) and how its calculation is done using the equation
T(Q) = (max( I ( x, y, z ) )/ P ) × Q.

Tzk = max( I ( x, y , z ) / P ) × Q zk + 1

k
(T ) > 0
H SG

if

(3.21)

We observed that if the threshold was moved by one bin the algorithm was able to
segment the tumor. After identifying if the HT algorithm has failed we moved the threshold by
one bin thereby altering the HT algorithm. The formulation of new threshold in the altered HT
algorithm is given in Equation 3.21, which is applied after two conditions are satisfied, one is
that stopping condition Tzk = Tzk −1 is reached and other is the condition when the value of the
k
histogram of the segment is greater than zero at the threshold Tzk and it is given by H SG
(Tzk ) >

0.
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Figure 3.6 The progression of altered HT algorithm with at (a) iteration 1, (b) iteration 5 and (c)
iteration 30.

a

b

c

Figure 3.7 (a) Original image with ROI. (b) The segmentation of the tumor fails with the
application of the original HT algorithm. (c) The altered HT algorithm was able to successfully
segment the tumors.
From Figure 3.6 we can see that the histogram of BK and SG get well separated by the
time the altered HT algorithm reaches 30 iterations. Figure 3.7 (a) shows the original image on
which both the HT and altered HT algorithm was applied and its results are shown in Figure 3.7
(b) and Figure 3.7 (c), respectively. The altered HT algorithm was successful in separating
background and tumor, whereas the original HT algorithm completely failed.
3.7 DISCUSSION
During the formulation of the HT algorithm the fact that data in the clinical images would
have more heterogeneous activity profile compared to the phantom data was considered. That is
the reason why the algorithm was applied in 2D instead of 3D. The effectiveness of the 2D
compared to 3D was never tested in phantom data because it is very difficult to create
heterogeneous activity profile in the physical phantom, but it is possible to mimic the condition
in the simulated phantom. The altered HT algorithm is applied only once the stopping condition
is satisfied; this pre-condition increases the computational time, but not by much.
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3.8 CONCLUSION
The altered HT algorithm performance can be further tested on simulated phantom data
with heterogeneous activity profile in the background. If the altered HT algorithm works on
clinical data it should also work in the phantom data. The new values FV and mAC in phantom
data is calculated by application of the altered HT algorithm and the new results are compared
with results acquired from the original HT algorithm. The altered HT will change the FV and
mAC values but it should not be significant.
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CHAPTER 4

Volume of interest generating algorithm
4.1 INTRODUCTION
The iterative deconvolution thresholding segmentation (IDTS) algorithm is semiautomatic because it requires the user to draw a region of interest (ROI) at the first step. The
user has to decide which tumor is to be segmented or the user can segment multiple tumors
within a specific organ. In phantom data the ROI was drawn on one transverse slice, which the
user had to select, and that one ROI was used for all the slices. This approach is impractical in
clinical images where many organs have activity profiles similar to the tumors. The algorithm
should also be capable of segmenting tumors from a specific organ as there are therapies like
selective internal radiation therapy (SIRT) which would only require volume of tumors in liver.
As the efficicy of a therapy is dependent on segmenting tumors from the right organ the single
slice ROI drawing is modified into a volume of interest (VOI) generating algorithm. The VOI
generating algorithm makes the application of the IDTS algorithm in the clinical data less time
consuming. The VOI still requires the user to draw the ROI but instead of drawing on one
transverse slice, three ROIs have to be drawn, one in the coronal slice followed by the sagittal
slice and than last in the transverse slice.
4.2 PROBLEM WITH DRAWING ONE REGION OF INTEREST
There are organs like kidney, spine, heart, bladder and many others which can sometimes
show activity similar to the tumor. An algorithm which attempts to automatically segment
tumors without the information of the organ in which the tumor is located may result in
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segmenting any of the above mentioned organs unintentionally. Segmenting organs together with
the tumor would render any algorithm useless. It will also reduce the confidence of the
radiologist towards the results obtained. If the algorithm is not able to differentiate between
tumor and organ, the process would be very time consuming as the radiologist would have reanalyze results and manully remove all the organs before applying the segmentation algorithm.
Figures 4.1-4.3 shows examples of clinical images where the activity of the kidney, heart,
and spine, respectively are similar to the activity of the tumor. In Figure 4.1.a we observe that the
kidney has a similar activity profile as the tumor and hence a ROI on that slice, avoiding the
kidney, will not ensure that the same ROI will not include the kidney on another slice. To avoid
this problem we might want to draw the ROI in the sagittal view as the kidney location is clearly
visible. However, that choice cannot be universally applied to all images as can be seen in
Figure 4.2, which shows that in the sagittal view we would fail to see the heart clearly. A similar
problem is demonstrated in the coronal view as seen in Figure 4.3, where it is difficult to draw a
ROI without avoiding the spine. In order to overcome this problem we have developed a VOI
generating algorithm.
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a

b

c

Transverse
Sagittal

Coronal

Figure 4.1 Example of clincial data where the activity of the kidney is similar to the tumor (a)
transverse slice (b) coronal slice (c) sagittal slice.

39

a

b

c

Transverse
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Coronal

Figure 4.2 Example of clincial data where the activity of the heart is similar to the tumor (a)
transverse slice (b) coronal slice (c) sagittal slice.
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Figure 4.3 Example of clincial data where the activity of the spine is similar to the tumor (a)
transverse slice (b) coronal slice (c) sagittal slice.

4.3 VOLUME OF INTEREST GENERATING ALGORITHM
The VOI generating algorithm first genarates a maximum intensity projected (MIP) image in the
coronal view of a 3D image I(x,y,z) where x = [1,2,..,X], y = [1,2,..,Y] and z = [1,2,..,Z]. The MIP
in the coronal view is the maximum of image I(x,y,z) in the y direction and is givien by

I coronal ( x, z ) = max I ( x, y.z ) . Similarly MIP in sagittal and transverse are the maximum of image
y

I(x,y,z)

in

x

and

z

direction

and

are

I transverse ( x, y ) = max I ( x, y.z ) , respectively.
z
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given

by

I sagittal ( y, z ) = max I ( x, y.z )
x

and

a

b

c
d

e

Figure 4.4 Outline of the VOI generating algorithm (a) Original image (b) ROI on MIP in
coronal view (c) ROI on MIP in sagittal view (d) ROI on MIP image in transverse view and (e)
showing 3D rendering of the VOI (red).

Figure 4.4 provides the outline of the overall algorithm. First a ROI is drawn in the
coronal MIP image I coronal ( x, z ) and given by ROI coronal ( x, z ) . It is followed by drawing ROI in
sagittal MIP image given by I sagittal ( x, z ) called ROI sagittal ( x, z ) the formulation of transverse
MIP is given below
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I transverse ( x, y ) = max ( I ( x, y, z ) • ROI coronal ( x, y ))
z

(4.1)

Equation 4.1 provides the coronal MIP in a transverse slice generated between the ROI in the
coronal view. In Figure 4.4.b, the limits of the ROI coronal ( x, z ) in z direction are used to genrate

ROI transverse ( x, z ) . The intersection between three ROI is the VOI and is given in Equation 4.2
below.
VOI = ROI coronal ( x, z ) ∩ ROI sagittal ( y, z ) ∩ ROI transverse ( x, y )

(4.2)

Figures 4.5 and 4.6 show clinical data from two patients. In both cases, the VOI was able to
successfully surround the region in the liver and avoid the kidney and other organs.
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Figure 4.5 Transverse view of slices of patient 1 where the VOI (red) only surround the region in
the liver and avoids the kidney and spine.
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Figure 4.6 Transverse view of slices of patient 2 where the VOI (red) only surround the region in
the liver and avoids the kidney and spine.

4.4 DISCUSSION
The method proposed herein has increased the user input from drawing the ROI on one slice to
drawing the ROI on three different views. Li, et al and Dewalle-Vignion, et al have generated
VOIs where in the case of Li, et al the VOI was just a 3D box and in the case of DewalleVignion, et al the VOI was generated using MIP images [31, 52]. But in Dewalle-Vignion et al
the VOI was only applied to tumors in head and neck where the occurrences of multiple organs
and tumors in the neighboring region are not visible.
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4.5 CONCLUSION
The proposed algorithm of VOI generation is simple and fast and would lend confidence to the
results obtained. The usefulness of the algorithm still needs to be tested in the clinical
environment where the input of the users and their learning curve have to be considered. Some
knowledge about how optimally a person can draw VOI will need to be obtained.
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CHAPTER 5

Results
5.1 PHYSICAL PHANTOM STUDIES (HOMOGENEOUS TUMORS)
5.1.1 INTRODUCTION
The partial volume effect (PVE) causes the activity in the tumor to spill out into the
background; the counts are preserved but spread over a larger area. Definitively validating tumor
volume in clinical data presents a challenge, making it important to validate the performance of
the algorithm first in the phantom data. The phantom data represents simpler cases compared to
clinical data, but if an algorithm fails to perform on phantom data it is unlikely to work on
clinical data. Validation of clinical data is presented in later section.
The phantom data are categorized into two types: physical and simulated. Physical
phantom data is generated by taking images of a plastic phantom that is filled with water and
radio-isotope using a PET camera. Most of the manufacturers of physical phantoms provide
spherical inserts which also can be filled with water and radio-isotope in order to simulate a
tumor. The anthropomorphic mathematical models like NCAT and ZUBAL are used to generate
simulated phantoms [53, 54]. The simulated phantoms are further sub-divided into simple and
complex. A simple simulated phantom is generated by convolving Tthe image with a point
spread function (PSF) and adding Gaussian noise. The PSF is a Gaussian function whose full
width half maximum (FWHM) is equal to the camera’s spatial resolution [42]. The standard
deviation of Gaussian noise is inversely proportional to the scan time. A complex simulated
phantom data is generated by using the Monte-Carlo method to simulate the physical process and
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instrumentation of a PET camera. The software packages that can be used to generate MonteCarlo based projection data are GATE, SimSET and PET-SORETO [55-57]. Once the projection
data is achieved they are reconstructed and an open source software that is widely used is called
software for topographic imaging reconstruction (STIR) [58].
5.1.2 PHYSICAL PHANTOM DATA
In order to validate our algorithm, physical phantom studies were performed using the
LiquiPhil Organ Scanning phantom manufactured by the Phantom Laboratory. The volume of
the phantom is 11 L. The tumors were represented by hollow spheres of different sizes (0.5, 1, 2,
4, 8 and 16 ml). They were filled with water and 18F-FDG 7 (1 or 2 mCi/L) and inserted into the
phantom which was filled with water and 18F-FDG (0.13-0.45 mCi/L) for different SBRs (2.75,
4.4, 5.5, 7.3 and 8.8).
The imaging experiments were performed using a GE Discovery Light Speed scanner at the
Baptist Hospital of Miami. The size of the entire image was 128 x 128 x 83 or 192 x 192 x 83,
and the dimensions of each voxel were 5.46 x 5.46 x 3.27 mm or 3.64 x 3.64 x 3.27 mm
respectively. The acquisition was performed at two bed positions using list-mode and the time
for each scan was five minutes. To compare the effects of count statistics, scans for three-minute
and one minute durations were derived from the five-minute list-mode data. The image
reconstructions were performed using the camera manufacturer’s built-in VUE point algorithm
with two iterations and 18 subsets; the cut-off filter was 6.4 mm. The VUE point algorithm is a
maximum likelihood ordered subset expectation maximization (ML-OS-EM) iterative
reconstruction algorithm which incorporates the random and scatter correction in the ML-OSEM equation [59].
7

Floride-18-Fluro-deoxy-glucose
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The algorithm was tested by varying the parameters in the algorithm, as well as the SBR and
image acquisition time, which affects the overall image counts. Within the algorithm, the
parameters that were changed were the shape and size of the manual ROI, the FWHM of the
Gaussian PSF used in the deconvolution algorithm, and the size of the Gaussian PSF.
5.1.3 TESTING THE IMPACT OF MANUAL DRAWING OF REGION OF INTEREST
The drawing of region of interest (ROI) is the only manual input required to start the
algorithm. As this is the starting step, it is critical that the shape and size of the ROI does not
impact the final result.

Figure 5.1 Three types of manually drawn ROI (a) The ROI is drawn on every slice close to the
tumor. (c) The ROI is drawn on one slice and drawn bigger than the tumor. (e) The ROI drawn
includes multiple tumors. (g) A very large ROI is drawn on one slice. (b, d, f and h) Result after
segmentation, where in h, the segmentation completely fails.
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To explore the limits of what shape and size of ROI we can draw, four methods of ROI
drawing were tested (Figure 5.1). In the first method the ROI was drawn on every slice where the
tumor was visible. As this method is considered the most accurate, it is compared with the other
three methods (Figure 5.1. a). The second method involved drawing the ROI only on one slice
and projecting that ROI onto every other slice (Figure 5.1. c). The third method involved
drawing the ROI over multiple tumors in one slice (Figure 5.1. e). And the fourth method
involved drawing a very large ROI with only a few pixels outside the ROI (Figure 5.1. g). The
volume obtained from the second and third method of drawing the ROI was the same as with the
first method. The segmented tumors in the first three methods were highly correlated spatially
(Figures 5.1 b, d and f). But with the fourth method (Figure 5.1 h) the algorithm completely
failed to segment tumors from the background.
5.1.4 RESULTS FROM HT ALGORITHM
For the algorithm to successfully estimate FV it is necessary to segment the tumors with their
entire associated blur from the background. Moreover, the SG volume (SG volume is the volume
of segment SG) should always be greater than the true volume. The FV is highly dependent on
the SG volume, and any change in the SG volume greatly affects the final FV.
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Figure 5.2 The ratio of SG volume/True volume after HT algorithm for different SBR.

Figure 5.2 shows a plot of the ratio of SG volume to true volume for different SBR and for
different tumor sizes. The plot shows SG volume for a 5 minute scan time and pixel size of 5.46
mm; SG volume for 1 and 3 minute scan times and 3.64 mm pixel sizes are not shown because
they all show a similar pattern. SG volume is almost double the true volume for all sizes of
tumors and the ratio of SG volume to true volume increases as the size of the tumor decreases.
The amount of blur increases as the SBR increases and (SG volume)/(true volume) ratio shows
that blur is dependent on SBR. The ratio of the SG volume to true volume is lowest at SBR of
2.75, and the ratio increases as the SBR increases (Figure 5.2). In Figure 5.2 it can be seen that
there is a large variation in the ratio of SG volume to true volume in small tumors (<2ml) for
SBR of 2.75 compared to SBR of 7.3. The increase in tumor size reduces the variation in the
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measurement of (SG volume)/(true volume). The variation is the standard deviation between two
scans with the same SBR, acquisition time and reconstruction parameters.
5.1.5 THE FINAL FV AND RC AND ROBUSTNESS OF THE IDTS ALGORITHM
The SG volume was used as the input for the IDTS algorithm to calculate the final FV. This
step was fully automated and the performance of the algorithm was tested by varying different
parameters. The performance of the IDTS algorithm upon varying different parameters is
demonstrated in Figures 5.3-5.8 for different pixel sizes of 5.46 mm and 3.64 mm. The error bars
in Figure 5.3-5.8 correspond to the standard deviation between two phantom data sets with same
SBR and acquisition time. Figures 5.3, 5.5 and 5.7 are plots showing results of the FV estimation
in terms of percentage of true volume (% of true volume), which is given by Equation 5.1 below.
Figures 5.4, 5.6 and 5.8 are plots showing results of AC estimation and are plotted in terms of
RC, where RC is ration of measured AC by known AC. (Equation 5.2 below).
% of true volume =

RC =

FV
× 100
true volume

(5.1)

AC
× 100
Known AC

(5.2)

Where FV is the measured functional volume of the segmented tumor (Equation 3.11) and the
AC is measured using Equation 3.13.

52

Figure 5.3 FV for different SBR by changing FWHM (4 mm, 6 mm, 8 mm and 10 mm). The FV
in (a), (b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The scan
time is 5 min and matrix size is 5 × 5. Error bars correspond to standard deviation of the number
of data sets (n=2).
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Figure 5.4 RC for different SBR by changing FWHM (4 mm, 6 mm, 8 mm and 10 mm). The RC
in (a), (b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The scan
time is 5 min and matrix size is 5 × 5. Error bars correspond to standard deviation of the number
of data sets (n=2).
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Figure 5.5 FV for different SBR by changing matrix size (3 × 3, 5 × 5 and 7 × 7). The FV in (a),
(b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The scan time is
5 min and FWHM is 6 mm. Error bars correspond to standard deviation of the number of data
sets (n=2).
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Figure 5.6 RC for different SBR by changing matrix size (3 × 3, 5 × 5 and 7 × 7). The RC in (a),
(b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The scan time is
5 min and FWHM is 6 mm. Error bars correspond to standard deviation of the number of data
sets (n=2).
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Figure 5.7 FV for different SBR by changing scan time (1 min, 3 min and 5 min). The FV in (a),
(b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The FWHM is
kept at 6 mm and matrix size is 5 × 5. Error bars correspond to standard deviation of the number
of data sets (n=2).
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Figure 5.8 RC for different SBR by changing scan time (1 min, 3 min and 5 min). The RC in (a),
(b) and (c) is for pixel size 5.46 mm and in (d), (e) and (f) pixel size is 3.64 mm. The FWHM is
kept at 6 mm and matrix size is 5 × 5. Error bars correspond to standard deviation of the number
of data sets (n=2).
In Figure 5.3 the FWHM of the Gaussian PSF was changed to assume values of 4, 6, 8
and 10 mm. The FWHM was not chosen lower than four because at the lower FWHM (<4) the
deconvolution algorithm is unable to remove the blur completely. For Figure 5.3, three levels of
SBR were chosen (2.75, 4.4 and 7.3). The results shown are for a 5 min scan, and the matrix size
of the PSF was kept at 5 × 5. The FV shown in Figure 5.3 was used to calculate the RC of the
AC (Figure 5.4). The impact of the matrix size of the Gaussian PSF was tested by considering
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sizes of 3 × 3, 5 × 5 and 7 × 7. The FWHM and acquisition time were kept constant at 6 mm and
5 min, respectively. Figure 5.5 shows the FV and Figure 5.6 shows RC for different PSF matrix
sizes. The algorithm performance was also tested by varying the acquisition time to observe the
variation in FV and RC due to the different noise levels. FV and RC are shown in Figure 5.7 and
Figure 5.8, respectively, with FWHM and matrix size of PSF kept constant. The approximate
mid value among the range of FWHM and matrix size tested was chosen to be 6 mm and 5 × 5,
respectively.
FV and RC results (Figures 5.3-5.8) were measured over multiple parameters. To make a
better comparison of results from the proposed algorithm to those published in other literature,
the FV and RC were plotted by keeping most of the parameters constant and varying only the
tumor size and SBR. The parameters chosen to be kept constant were pixel size, FWHM, matrix
size and acquisition time, whose values were 3.64 mm, 5×5 and 5 min respectively (Figures 5.8).
The criterion for choosing the values of the above parameters was that they gave the best results
for FV and RC.
5.1.6 STATASTICAL ANALYSIS OF PHANTOM STUDIES
The goal of this project was to develop a numerical algorithm that will provide accurate
estimates of liver tumor Functional Volume (FV) and activity Recovery Coefficient (RC) with
minimal input required from a physician or technologist, and further that it would be independent
of the camera used to collect the images. To this end numerous parameters related to the quality
of the image including noise (acquisition time), SBR (signal to background ratio), and
parameters specific to the camera and reconstruction including FWHM (full width half max of
the camera’s point spread function), matrix size and image size were varied and their impact on
FV and RC observed. From the graphs in Figures 5.3-5.8, 2 parameters were kept constant and
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the other 4 were changed so that the data could be more easily visualized on a 2-dimensional
plot. However, this representation fails to provide a concise way to allow a clear understanding
of which parameters are the major contributor to the variation in the results. To help in the
understanding of the contribution of each parameter we designed a factorial analysis and
measured the Effect value of each parameter. The analysis consisted of calculating the effects of
each of the 6 factors in a statistical sense. The analysis is based on the physical phantom data of
homogeneous tumors with two replicates and is presented in the next section.
5.1.6.a Factorial analysis
The statistical analysis allows the testing of the hypothesis that the performance of the
algorithm is independent of the camera used to generate the images. There are in total six
parameters (factors) which were changed, as listed in Table 5.1. The two outputs or response
variables are FV and RC. The levels of the factors are also given in the table below.
Table 5.1 Parameters (factors) and their values (levels) used in the factorial analysis. All factor
levels are treated as nominal data.
Image size

5.46 mm

3.64 mm

Acquisition time

1 min

3 min

5 min

Signal to background ratio

2.75

4.4

8.8

Matrix size

3×3

5×5

7×7

FWHM

4 mm

6 mm

8 mm

10 mm

Tumor volume

0.5 ml

1 ml

2 ml

4 ml
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8 ml

16 ml

The Effect values were calculated using the software Design Expert 8.0. The Image size is
the size of each pixel in the image. Acquisition time is related to noise and thus shorter scanning
time equates to higher noise and longer scanning time equates to lower noise. Three levels of
signal to background ratio (SBR) are used. Matrix size is the size of the point spread function
(PSF) and full width half maximum (FWHM) of the PSF. Tumor volume is the known volume of
spheres. The Effect values and p-values were calculated for each parameter and are listed in
Table 5.2.
Figure 5.9 is a plot of the Effect values for each Tumor volume. In Figure 5.9.a the response
variable is FV and in Figure 5.9.b the response variable is RC. Figure 5.9 shows that the FWHM
has no significant impact on the FV and RC. It can also be observes that the Image Size has a
significant impact on FV and RC for the 16 ml Tumor. Image Size was changed post
reconstruction and its impact on other parameters cannot be known from the current statistics. It
is known from the literature that the tumor size has the most impact on the RC, which is also
confirmed by our statistical analysis and shown in Figure 5.10.b. SBR and Acquisition Time are
also known to have significant impact on the FV and RC measurement and is also confirmed by
the analysis of our algorithm. These finding are not surprising, but the statistical analysis
provides an appreciation of the degree of contribution of these factors on the algorithm’s
performance.
Figure 5.10 is a plot of the Effect values of all 6 parameters (factors), including tumor
size, for the two response variables FV (Figure 5.10.a) and RC (Figure 5.10.b). The FWHM has
no impact on the FV and RC, and Matrix Size has little effect, except for perhaps the largest
tumor. This finding supports the hypothesis that the algorithm is independent of the camera used
to collect the images and suggests that the algorithm can confidently be applied on images
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acquired from different cameras. Further, the statistics prove that the algorithm could accurately
perform PVE correction without knowing the spatial resolution of the camera.
There is an interesting amplification of the effect of Image Size on FV and RC that is
difficult to explain without further investigation. It could be that the accuracy and precision of
the FV and RC estimates for the largest tumor was such that high statistical significance was
obtained, while there may be little practical significance. A more in depth analysis of these
results still must be done.
The Effect values due to the interaction of different parameters (factors) are shown in
Table 5.2 and Table 5.3 for response variable FV and RC respectively. The primary purpose of
doing this statistical analysis was to show that FWHM has no impact on the FV and RC. We also
wanted to observe the best parameter value that would provide an accurate estimation of FV and
RC. The current statistical study is unable to provide the best parameters because the factor level
values are nominal rather than numerical. This precludes a quantitative model fit. To find the
optimal parameters, the statistics would have to be done for each sub levels of the parameter and
this could be further investigated. This was outside the scope of this dissertation.
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Figure 5.9 Contribution of different parameter in terms of effect values in measurement of (a) FV and (b) RC for different size tumors.
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Figure 5.10 Contribution of different parameters in term of Effect values for measuring
(a) FV and (b) RC considering true volume (TV) as one of the parameter.

Table 5.2 Effect values of each of the parameters (factors) and their corresponding
interaction for the response variable FV. (TV = tumor volume, IS = image size, AT =
aqusition time, SBR = signal to background ratio, MS = matrix size and FWHM = full
width half maximum)
Term

df

SumSqr

MeanSqr

Prob>F

F Value

%Contribution

A-TV

5

10.36352

2.072704 < 0.0001

48.42853

7.290664

B-IS

1

3.964439

3.964439 < 0.0001

92.62873

2.788955

C-AT

2

10.40554

5.202771 < 0.0001

121.5622

7.320225

D-SBR

2

19.17799

9.588996 < 0.0001

224.0459

13.49158

E-MS

2

0.890347

0.445173 < 0.0001

10.40143

0.626352

FWHM

3

0.003339

0.001113 0.9943

0.026004

0.002349

AB

5

9.30996

1.861992 < 0.0001

43.50526

6.54949

AC

10

1.508862

0.150886 0.0001

3.525441

1.061474

AD

10

10.81621

1.081621 < 0.0001

25.27197

7.609127

AE

10

2.072835

0.207283 < 0.0001

4.843157

1.458224

AF

15

0.006004

0.0004 1.0000

0.009352

0.004223

BC

2

0.271572

0.135786 0.0422

3.172621

0.191049

F-

77

BD

2

1.621757

0.810879 < 0.0001

18.9461

1.140895

BE

2

0.515191

0.257595 0.0025

6.018691

0.362433

BF

3

0.00019

6.34E-05 0.9999

0.001482

0.000134

CD

4

1.604313

0.401078 < 0.0001

9.371155

1.128623

CE

4

0.15191

0.037977 0.4707

0.887339

0.106867

CF

6

0.003209

0.000535 1.0000

0.012496

0.002257

DE

4

0.15433

0.038583 0.4623

0.901478

0.10857

DF

6

0.002957

0.000493 1.0000

0.011515

0.00208

EF

6

0.010082

0.00168 0.9997

0.039261

0.007093

ABC

10

1.302063

0.130206 0.0008

3.042257

0.915992

ABD

10

3.226012

0.322601 < 0.0001

7.537544

2.269476

ABE

10

0.401495

0.040149 0.4968

0.938089

0.282449

ABF

15

0.009914

0.000661 1.0000

0.015442

0.006974

ACD

20

2.767085

0.138354 < 0.0001

3.232633

1.946624

ACE

20

0.4242

0.02121 0.9692

0.49557

0.298422

ACF

30

0.015153

0.000505 1.0000

0.011802

0.01066

ADE

20

0.552446

0.027622 0.8802

0.645392

0.388641
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ADF

30

0.027352

0.000912 1.0000

0.021302

0.019242

AEF

30

0.02769

0.000923 1.0000

0.021566

0.01948

BCD

4

0.717984

0.179496 0.0022

4.193908

0.505097

BCE

4

0.058014

0.014503 0.8518

0.338872

0.040812

BCF

6

0.004734

0.000789 1.0000

0.018436

0.00333

BDE

4

0.222685

0.055671 0.2677

1.300752

0.156657

BDF

6

0.006575

0.001096 0.9999

0.025602

0.004625

BEF

6

0.010331

0.001722 0.9997

0.040229

0.007268

CDE

8

0.009491

0.001186 1.0000

0.027718

0.006677

CDF

12

0.017419

0.001452 1.0000

0.033915

0.012254

CEF

12

0.012921

0.001077 1.0000

0.025158

0.00909

DEF

12

0.017133

0.001428 1.0000

0.033359

0.012053

ABCD

20

2.066249

0.103312 0.0005

2.413885

1.453591

ABCE

20

0.224474

0.011224 0.9996

0.262241

0.157916

ABCF

30

0.023025

0.000768 1.0000

0.017933

0.016198

ABDE

20

0.333605

0.01668 0.9930

0.389733

0.234689

ABDF

30

0.031553

0.001052 1.0000

0.024575

0.022198
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ABEF

30

0.019473

0.000649 1.0000

0.015166

0.013699

ACDE

40

0.165647

0.004141 1.0000

0.096758

0.116532

ACDF

60

0.053631

0.000894 1.0000

0.020885

0.037729

ACEF

60

0.099695

0.001662 1.0000

0.038823

0.070135

ADEF

60

0.048004

0.0008 1.0000

0.018694

0.033771

BCDE

8

0.074447

0.009306 0.9879

0.21743

0.052373

BCDF

12

0.016833

0.001403 1.0000

0.032775

0.011842

BCEF

12

0.007942

0.000662 1.0000

0.015464

0.005587

BDEF

12

0.013409

0.001117 1.0000

0.026108

0.009433

CDEF

24

0.028056

0.001169 1.0000

0.027314

0.019737

ABCDE

40

0.39272

0.009818 1.0000

0.229397

0.276276

ABCDF

60

0.06466

0.001078 1.0000

0.02518

0.045488

ABCEF

60

0.043165

0.000719 1.0000

0.016809

0.030366

ABDEF

60

0.049533

0.000826 1.0000

0.019289

0.034846

ACDEF

120

0.140967

0.001175 1.0000

0.027447

0.099169

BCDEF

24

0.027291

0.001137 1.0000

0.026569

0.019199

ABCDEF

120

0.113198

0.000943 1.0000

0.022041

0.079634
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Table 5.3 Effect values of each of the parameters (factors) and their corresponding
interaction for the response variable RC. (TV = tumor volume, IS = image size, AT =
aqusition time, SBR = signal to background ratio, MS = matrix size and FWHM = full
width half maximum)

Term

df

SumSqr

MeanSqr

Prob>F

F Value

% Contribution

A-TV

5

35.33211

7.066422 < 0.0001

958.7613

54.90496

B-IS

1

0.517484

0.517484 < 0.0001

70.21148

0.804154

C-AT

2

1.252574

0.626287 < 0.0001

84.97365

1.946459

D-SBR

2

2.540063

1.270032 < 0.0001

172.3159

3.947176

E-MS

2

0.385528

0.192764 < 0.0001

26.15396

0.599099

F-FWHM

3

0.003377

0.001126 0.9280

0.152713

0.005247

AB

5

0.813919

0.162784 < 0.0001

22.08626

1.264804

AC

10

0.38386

0.038386 < 0.0001

5.20815

0.596506

AD

10

5.75199

0.575199 < 0.0001

78.04212

8.938407

AE

10

1.142252

0.114225 < 0.0001

15.49791

1.775023

AF

15

0.011033

0.000736 1.0000

0.099797

0.017145

BC

2

0.036251

0.018125 0.0859

2.459226

0.056333
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BD

2

0.770782

0.385391 < 0.0001

52.28929

1.197771

BE

2

0.2767

0.13835 < 0.0001

18.7711

0.429983

BF

3

0.000982

0.000327 0.9876

0.044424

0.001526

CD

4

0.406171

0.101543 < 0.0001

13.77718

0.631177

CE

4

0.062159

0.01554 0.0776

2.108421

0.096594

CF

6

0.004955

0.000826 0.9951

0.11204

0.007699

DE

4

0.098234

0.024558 0.0100

3.332052

0.152652

DF

6

0.00456

0.00076 0.9961

0.103125

0.007087

EF

6

0.010153

0.001692 0.9671

0.229579

0.015777

ABC

10

0.272328

0.027233 < 0.0001

3.694905

0.423189

ABD

10

0.813934

0.081393 < 0.0001

11.04333

1.264828

ABE

10

0.33035

0.033035 < 0.0001

4.482143

0.513354

ABF

15

0.007522

0.000501 1.0000

0.068036

0.011689

ACD

20

0.628203

4.261679

0.976207

ACE

20

0.222477

0.011124 0.0691

1.509269

0.345723

ACF

30

0.017588

0.000586 1.0000

0.079545

0.027331

ADE

20

0.40855

0.020427 < 0.0001

2.771571

0.634873

0.03141 < 0.0001
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ADF

30

0.030158

0.001005 1.0000

0.136393

0.046864

AEF

30

0.035721

0.001191 1.0000

0.161554

0.05551

BCD

4

0.220091

0.055023 < 0.0001

7.465398

0.342014

BCE

4

0.032009

0.008002 0.3621

1.085746

0.049742

BCF

6

0.001124

0.000187 0.9999

0.025415

0.001747

BDE

4

0.175191

0.043798 < 0.0001

5.942414

0.272241

BDF

6

0.005289

0.000882 0.9941

0.119606

0.008219

BEF

6

0.014567

0.002428 0.9217

0.329406

0.022637

CDE

8

0.028795

0.003599 0.8651

0.488359

0.044747

CDF

12

0.008226

0.000686 1.0000

0.093008

0.012783

CEF

12

0.009252

0.000771 0.9999

0.104608

0.014377

DEF

12

0.02196

0.00183 0.9956

0.248291

0.034125

ABCD

20

0.299555

0.014978 0.0046

2.032155

0.465498

ABCE

20

0.144571

0.007229 0.4830

0.980761

0.224659

ABCF

30

0.015998

0.000533 1.0000

0.072352

0.02486

ABDE

20

0.157992

0.0079 0.3735

1.071803

0.245514

ABDF

30

0.020253

0.000675 1.0000

0.091598

0.031473
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ABEF

30

0.026842

0.000895 1.0000

0.121395

0.041711

ACDE

40

0.188262

0.004707 0.9617

0.638579

0.292554

ACDF

60

0.048117

0.000802 1.0000

0.108808

0.074773

ACEF

60

0.055392

0.000923 1.0000

0.125259

0.086078

ADEF

60

0.064556

0.001076 1.0000

0.145982

0.100319

BCDE

8

0.059716

0.007464 0.4242

1.01277

0.092797

BCDF

12

0.003856

0.000321 1.0000

0.043596

0.005992

BCEF

12

0.009261

0.000772 0.9999

0.104709

0.014391

BDEF

12

0.018181

0.001515 0.9983

0.205564

0.028253

CDEF

24

0.021849

0.00091 1.0000

0.123518

0.033953

ABCDE

40

0.280387

0.00701 0.5587

0.951062

0.435713

ABCDF

60

0.033937

0.000566 1.0000

0.076743

0.052738

ABCEF

60

0.036593

0.00061 1.0000

0.082747

0.056864

ABDEF

60

0.042102

0.000702 1.0000

0.095205

0.065425

ACDEF

120

0.088019

0.000733 1.0000

0.099519

0.136779

BCDEF

24

0.026869

0.00112 1.0000

0.151897

0.041753

ABCDEF

120

0.07599

0.000633 1.0000

0.085918

0.118086
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5.1.7 DISCUSSION
The main purpose of the proposed algorithm is to give accurate FV estimates and
3D contour of tumors which would help in the determination of the appropriate radiation
dose for radiotherapy (e.g Y-90 microspheres SIRT, IMRT and radio-immunotherapy).
The AC and Total Lesion Glycolysis (TLG) are also very useful in monitoring response
to therapy, and TLG relies on accurate FV estimates. The algorithm described in this
study is robust in that the shape and size of the user-defined ROI has no impact on the
accuracy of the FV, as long as the ROI is within the organ of interest. Similarly, for a
phantom experiment, the ROI must be positioned within the phantom. The contour of the
ROI must be smaller than the size of the body because the HT algorithm requires the
generation of two histograms, one for ROI and another for background. If the ROI is too
large then there would be too few pixels in the background and a very small background
region compared to the ROI which would not be adequate enough to sample the entire
spectrum of the background (Figure 5.1. h). This would cause the HT algorithm to
incorrectly calculate the threshold value.
Li et al. used a Region Growing algorithm to achieve the segment similar to the
HT algorithm [31]. In the Li et al. algorithm the identification of maximum intensity was
used as an initiation point for the algorithm. An advantage of the proposed algorithm
compared to that of Li et al. is that it can segment multiple tumors within a given ROI
since the HT algorithm is not based on maximum intensity. The HT algorithm, in some
slices, segments isolated pixels or isolated clusters which are not part of any of the
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tumors, due to the noisy nature of PET images. These isolated pixels can be easily
removed by using region labeling.
Blur is removed from the segment (SG) using the IDTS algorithm. The maximum
intensity value (MV) within the tumor is used in one of the stopping conditions to reach
accurate volume estimation (Equation 3.15). The maximum intensity has been typically
used to measure SUVmax and is least affected by PVE [15]. The maximum intensity of an
image could be affected by noise, but the algorithm was tested for different noise levels
by collecting images at different acquisition times (Figures 5.7 and 5.8). Additionally,
the MIC algorithm was used to correct the maximum intensity for tumors smaller than
1.8 ml. The algorithm chooses the tumor on which the MIC algorithm can be applied
automatically. To do this the algorithm measures the FV of each tumor and if it finds any
tumor whose volume is less than 1.8 ml the MIC algorithm is applied on that particular
tumor and the FV is recalculated.
Hatt et al. have been able to show high accuracy in estimating FV but they are not
able to identify FV of tumors smaller than a diameter of 10 mm [44]. In contrast, our
algorithm is able to segment and calculate the FV of tumors less than 10 mm. Apart from
FV estimation; the algorithm is also able to measure the activity concentration of the
tumor. The purpose of the development of this algorithm is to segment tumors, while at
the same time estimate FV and measure PVE corrected activity concentration (AC).
Kirov et al. and Teo et al. have successfully corrected the PVE using
deconvolution [49, 50]. Both methods require estimation of the PSF of the camera.
Barbee et al. used a non-isotropic PSF which was estimated by fitting the blur to a

86

Gaussian function [14]. But the PSF was measured by doing phantom studies where a
cylinder filled with

18

F-FDG within the phantom was used as a point source while no

activity was in the remainder of the phantom resulting in a very favorable SBR. The
amount of blur in a tumor is also dependent on the SBR so it would be difficult to predefine the PSF [15]. In the cases of Kirov et al. and Teo et al. the number of iterations of
the deconvolution algorithm applied had to be optimized based on phantom studies [49,
50]. In our algorithm the FV and PVE corrected RC are independent of the PSF used in
the deconvolution algorithm and thus there was no need to optimize the number of
iterations to get the final FV.
The value of FV is dependent on SG volume. In Figure 5.2 the variation in SG
volume at SBR 2.75 leads to high variation in FV, as seen in Figure 5.3.a. This variation
in SG volume could be due to the noise level in the image, which affects the HT
algorithm for small tumors (< 2 ml) the most. In Figure 5.3.c the FV is closer to the
actual volume at SBR 7.3, with minimal variation compared at SBR 2.75. Accurate FV
leads to accurate RC as seen in Figure 5.4.c. Figures 5.3 and 5.4 show that the variation
in FV and RC due to the use of different FWHMs in the algorithm is minimal. However,
the size of the matrix of the PSF shows variation in FV and RC for small tumors (< 2ml).
The matrix sizes of 3 × 3 and 5 × 5 give better FV and RC compared to matrix size of 7 ×
7. However, for large tumors the matrix size shows minimal variation (Figures 5.5 and
5.6). Hence in any further application of the IDTS algorithm, matrix sizes less than 7 × 7
should be chosen. The proposed algorithm is impacted by the acquisition time, where the
acquisition time of 1 min showed the biggest error compared to 3 min and 5 min scan
times (Figures 5.7 and 5.8).
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Furthermore, our algorithm as designed determines not only the SG which
contains the total activity compensated for spill-out, but also obtains the FV. By simply
dividing the total activity by the total number of voxels belonging to FV (VO) we can
obtain the mean activity concentration (mAC). This gives a better measurement of the RC
of a tumor without the need to estimate the PSF of the camera; it was able to correct for
the RC just by obtaining the VO. The RC is usually measured using the maximum
activity of a lesion [15, 49], but in this algorithm it is able to achieve the RC based on the
mAC. RC is used to evaluate the accuracy of AC. The AC is used for measuring
SUVmean and SUVmax. The SUVmax is based on the one pixel with maximum intensity
making it vulnerable to noise and it is erroneous to use it for heterogeneous tumors. On
the other hand, the SUVmean is based on average intensity of all the voxels belonging to
tumor and its accuracy is dependent on FV. The SUVmean measured by our algorithm is
unique compared to any of the published algorithms because it uses PVE corrected FV
and blur included total activity to measure mAC. The SUVmean derived from our
algorithm is a better method to calculate SUV in clinical images compared to SUVmax.
Our algorithm has shown that the RC value as well as an FV estimate can be
obtained automatically. De Bernardi et al. presented an algorithm similar to our’s in the
sense that they were able to apply segmentation and PVE correction together, but the
algorithm was applied during reconstruction of an image as compared to the proposed
algorithm which is applied during post-processing [32], and therefore the algorithm could
be applied on an image provided by a clinician that has already been reconstructed. De
Bernardi et al. used the camera’s measured PSF to account for the spill-out of activity
outside of the tumor. The use of a camera’s PSF or a user defined PSF sets a great
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limitation on these previously reported algorithms [14] since the PSF may not be known
or not be obtainable by the clinician providing the reconstructed image set.
5.1.8 CONCLUSION
The algorithm developed has many unique features like the ability to measure
mean activity concentration and the usage of deconvolution to segment the tumor in
addition to correcting for PVE. The ability of the algorithm to generate consistent results
upon varying multiple parameters demonstrates its robustness to withstand the
complexity encountered in real clinical images.
5.2 PHYSICAL AND SIMULATED PHANTOM STUDIES (HETEROGENEOUS
TUMORS)
5.2.1 INTRODUCTION
Thus far the algorithm was tested on tumors with homogeneous activity profile,
which have much lower complexity than clinical data. The studies described in this
chapter explore the case of heterogeneous tumors. The IDTS algorithm has two stopping
conditions, the second stopping condition developed considering that there could be
heterogeneity within the tumors. For the studies described herein, heterogeneous tumors
were generated by both physical and simulated phantoms. In the physical phantom
studies the heterogeneous tumors were also irregular shaped making the segmentation
even more challenging, whereas in the simulated phantom data spherical phantom tumors
were still used.
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5.2.2 FV OF IRREGULAR SHAPED HETEROGENEOUS PHYSICAL TUMORS
The physical phantom used for irregular shaped phantom data is called LiquiPhil
phantom. The LiquiPhil phantom is provided with irregular shaped inserts in which we
can place the smaller spheres in order to mimic irregular shaped heterogeneous tumors as
shown in Figure 5.11. The volume of the organs are large (92-145 ml) and of the spheres
(0.5-8 ml). The irregular shaped heterogeneous activity simulated tumors were placed
inside the phantom to better represent a realistic clinical case. The irregular shaped
physical tumors had cores of different sizes (1, 2, 4 and 8 ml) which could be filled with
activity. The specifications of the heterogeneous tumors are given in Table 5.4 (below).

Figure 5.11 Schematic of a phantom with an irregular shaped heterogeneous physic
tumor (indicated by the red dotted circle).
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Table 5.4 Specifications of the irregular shaped heterogeneous physical tumor phantom
experiments.

Activity ratio between

Number

tumor and core

Activity ratio
between tumor and
background

Core volume

Tumor

(ml)

volume (ml)

Tumor1

3:1

8.25:1

8

145

Tumor2

3:0

8.25:1

4

92

Tumor3

1:3

2.75:1

2

137

Tumor4

1:2

2.75:1

2

137

Tumor5

2:1

5.5:1

4

94

Tumor6

2:0

5.5:1

8

137

. The activity levels in the irregular shaped tumor and spherical insert were kept
different from each other in order to achieve heterogeneity. The algorithm was tested on
these irregular shaped physical tumors (Figure 5.12). The tumors are visible in Figure
5.12.a and their corresponding segmentation is shown in Figure 5.12.b.
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Figure 5.12 Physical tumors with spherical cores of different activity concentrations to
represent tumors with heterogeneous uptake distribution. (a) Three tumors with spherical
cores, with different activity concentration between the tumors and their cores. The tumor
at the right has no activity in the core to simulate necrosis. (b) Segmentation of the three
tumors showing that the algorithm is able to segment the necrotic section within the right
most tumors.
In Figure 5.13 it is observed that the FV of 5 out of 6 tumors is very close to the
true volume, but in tumor 3 there is an underestimation in FV of ~10%. The FWHM was
6 mm and the matrix size of 5 × 5 was used during the application of IDTS algorithm.
The error bar shows variation due to different acquisition times (1 min, 3 min and 5 min).
Figure 5.13.a and Figure 5.13.b show FV for phantom data acquired at pixel sizes of 5.46
mm and 3.46 mm respectively. For tumors with necrotic cores the HT algorithm was able
to segment the core from the tumor in some of the slices, but failed to do so in the slices
where the area of the core was small and highly affected by PVE, that is, where the
intensity within the core was greater than the background intensity.
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Figure 5.13 The percentage of volume from irregular shaped heterogeneous simulated
tumors. (a) pixel size 5.46 mm and (b) pixel size 3.64 mm. The FWHM is kept at 6 mm
and matrix size is 5 × 5. Error bars correspond to the variation due to different image
acquisition times or image noise (5 min, 3 min and 1 min).
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5.2.3 COMPUTER SIMULATED PHANTOM DATA
The algorithm was tested on simulated data, where the tumors are incorporated
within the NCAT phantom.. Tumors manually segmented from a clinical

18

F-FDG -PET

image and given pixel intensity similar to what is observed in that clinical image was
placed within the liver in the NCAT simulated image. The tumor volume was 51 ml, with
the volume of each voxel being 0.03 ml. The size of the image was 128 × 128 × 128. To
simulate heterogeneous uptake, a second region of volume 6.87 ml was placed within the
tumor. The second region formed the heterogeneous core of the tumor, where different
activity concentrations of the tumor and the core could be maintained. Gaussian noise
was added with a mean of zero and variance of 0.001. The image was convolved with a
Gaussian PSF (FWHM of 6.5 mm) to simulate blur similar to the one observed in images
that are derived from the PET camera.
The simulated data, with known ground truth, helps to provide voxel to voxel
accuracy of the segmented tumor. The NCAT program was used to simulate nuclear
emission images of the abdomen in which a tumor with heterogeneous uptake was placed
inside the liver. Activity concentration ratios of 6:10 and 8:6 between tumor and its core
were chosen, and are referred to as Tumor 1 and Tumor 2, respectively. The image of
Tumor 1 is shown in Figure 5.14.
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Figure 5.14 NCAT simulated phantom where a heterogeneous tumor is incorporated
inside the liver, SUV of large tumor (51ml) is 6 and the SUV of the heterogeneous
section (6.8 ml) of the tumor is 9. The SUV of the liver and kidney is kept at 1.
The actual volume of the tumor was 51 ml and the percentage of true volume (%
of true volume), given by Equation 5.1 and classification error (CE) were estimated. CE
is a function of two types of errors; one is called positive classification error (PCE),
where voxels of the background are made part of the tumor and the other is called
negative classification error (NCE), where voxels of the tumor are made part of the
background (Equation 5.3).
CE =

PCE + NCE
×100
VO

(5.3)
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The percentage of true volume (% of true volume) only gives the correlation
between the numbers of voxels in the segmented tumor to the true number of voxels. But
CE also provides spatial correlation of each voxel, which can be used as an extra statistic
to measure the performance of the algorithm [2]. The results of the CE and percentage of
true volume (% of true volume) estimation with the different FWHM Gaussian PSF in the
deconvolution stage of IDTS algorithm is provided in Table 5.5 (below).
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Table 5.5 Percentage of true volume (% of True Volume) and classification error (CE) of
the algorithm in segmenting NCAT simulated heterogeneous tumors. The algorithm is
applied by changing FWHM from 4 mm, 6 mm, 8 mm to 10 mm. The matrix size of PSF
is kept at 5 × 5.
Activity ratio
Number

FWHM

between
background to
tumor to core

Tumor1

1:6:10

4mm

6mm

8mm

10mm

10.65

9.18

9.18

9.36

Volume

107.83

105.71

104.41

103.88

CE (%)

12.89

11.83

11.77

11.42

111.36

109.42

109.18

108.95

CE (%)
% of True

Tumor2

1:8:6

% of True
Volume

5.2.4 DISCUSSION
The computer simulated data used for testing the proposed algorithm is not as
realistic as the simulated data used by Hatt et al [44]. Hatt et al. used the Monte Carlo
based PET simulating software package GATE, which helps to include the variation of
the camera’s geometry and reconstruction algorithm [44, 45]. In this dissertation
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Gaussian noise and Gaussian blur were added to NCAT data to simulate PET images
with PVE. The simulated data presented by Belhassen et al. was used as a guide to
generate simulated data in this study [42]. Belhassen et al. used NCAT data with Poisson
noise added but without any addition of blur [42]. Interestingly, with the proposed
algorithm, the FV estimations for the physical phantom experiments were better than
those for the computer simulated phantom, but the differences were very small. The
results of the % of true volume and CE using the computer simulated phantom are around
10% for both Tumor 1 and Tumor 2, which is comparable to other algorithms cited in this
dissertation. Nevertheless the algorithm should be further tested on more realistic
simulated data. The RC of the hetereogeneous uptake tumors were not measured for both
physical phantom and simulated phantom. The explanation is that to measure the RC of
hetereogeneous uptake tumors would require measuring FV of different heterogeneous
sections within the tumor as well as their corresponding AC. Hatt et al. and Belhassen et
al. were able to segment tumors which have inhomogeneous uptake [42, 45]. Hatt et al.
were able to segment regions within the tumor. Yang et al. did segmentation of
heterogeneous region within the tumor. They used simulated data generated using
SimSet, which is still more advanced then my simulated data [60].

The proposed

algorithm was tested against tumors which have inhomogeneous uptake, but it did not
segment the regions within a tumor. Segmenting a region within the tumor (also called
sub-volume segmentation) could be a helpful feature that would be added to the IDTS
algorithm. Sub-volume segmentation enables the administration of adaptive modulating
radiation dose based on the criteria of whether the sub-volumes are necrotic or hypoxic.
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The algorithm still needs to be tested on an open source database of simulated PET data
to test its performance and also compare the results to published algorithms [61]..
5.2.5 CONCLUSION
In this chapter, our algorithm was used to segment heterogeneous tumors, which
is important because the activity profile of a heterogeneous tumor is closer to that of a
real tumor. The algorithm should always be tested on physical and simulated phantom
data as both have their advantages and disadvantages. The advantage of the physical
phantom is that the noise and blur are similar to real images. The disadvantage is that it
lacks ground truth (exact location and activity of a tumor) and while the amount of
activity can be varied, the shape and size remains fixed. The advantage of a simulated
phantom is that it provides the ground truth and there is no limit to how much the tumor
size, shape and activity could be varied; the disadvantage is that the noise and blur are not
as realistic as the physical phantom. .
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5.3 ALGORITHM APPLIED ON CLINICAL DATA
5.3.1 INTRODUCTION
Until now the algorithm has been tested on phantom data only, both physical and
simulated. In order for the algorithm to be acceptable it must be demonstrated
successfully on clinical images. We have applied our algorithm on 10 clinical data sets all
with hepatocellular carcinoma. The size and shape of each tumor is different. There are
some tumors which also have necrosis within them. This is a complex set of data with
which to test the performance of the iterative deconvolution thresholding segmentation
(IDTS) algorithm. There is no definitive way to validate the accuracy of an algorithm in
the clinical data, however. The gold standard that is considered here is manual
segmentation by a radiologist. To validate our algorithm we are comparing it with manual
segmentation and see if the results match or correlate. Also to give a better perspective,
the algorithm is compared to a fixed threshold method.
5.3.2 RESULTS OF THE CLINICAL DATA
To do the manual segmentation, the radiologist was required to draw manually a
region of interest (ROI) around each tumor on each slice. The time required by the
radiologist was around 2-3 three hours on average for each data set. Once the ROIs were
drawn they were compared with the manual segmentation and the error in the volume
was measured. The fixed threshold methods were also compared with the manual
segmentation method. The two fixed threshold methods used were 1) T50, which uses
50% of the maximum value as the threshold, and 2) T60 which uses 60% of the
maximum value as the threshold (Figure 5.15 below). The mean activity concentration
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(mAC) from the manual segmented tumor was also compared with mAC from IDTS
algorithm, T50 and T60.

Original
Image

IDTS

T50

T60

Patie
nt 1
Patie
nt 2
Patie
nt 3
Patie
nt 4
Patie
nt 5
Figure 5.15 The results from three methods of segmentation on 5 out of total 10 patient
data sets: column 1 shows the original image and column 2 shows the output of the IDTS
algorithm, and columns 2 and 3 give results of the application of T50 and T60
segmentation methods, respectively.
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Visually observing Figure 5.15, we can say that the T50 and T60 methods have
failed to accurately segment the tumors in most cases. The quantitative comparison of the
IDTS algorithm, T50 and T60 to manual segmentation is given in Table 5.6 (below). The
“Percentage of volume error” is the percentage difference between estimated FV
(calculated using algorithms) and the manually segmented volume. Similarly “Percentage
of mAC error” is the difference between estimated mAC and the mAC derived from
manual segmentation.

Table 5.6 Results showing percentage of volume error and percentage of mean activity
concentration (mAC) error of IDTS algorithm, T50 and T60 when compared to manual
segmentation

Method

Percentage of volume error

Percentage of mAC error

IDTS algorithm

-17% +/- 9%

15% +/-11%

T50

-60% +/- 33%

20% +/-13%

T60

-73% +/-47%

23% +/-16%
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5.3.3 DISCUSSION
. The most accurate way to validate the clinical image is to compare it with a
histological specimen to ensure that the volume is actually tumor. The histological
specimen is taken by surgically removing the tumor and measuring the volume and
comparing the volume with pre-surgery PET scans [62]. Such a comparison is not
possible in our study as the volumes were measured of tumors which were not resectable,
so manual segmentation was the only method available for the data to be compared. In
our study the results were compared to manual segmentation done by a radiologist giving
a comparison judgment.. There have been studies where the functional tumor volumes
(FVs) were compared to manual segmentation in CT images [48, 63, 64]. The CT images
are a good choice for comparison but have several drawbacks as well. CT images within
a PET machine are not of high resolution whereas using stand-alone CT images would
require co-registration of the images. For the best comparison, contrast CT images should
be used as it is easy to manually segment the tumor in them. Still CT images cannot show
necrosis within the tumor. In Figure 5.15, for patient 5 we see the tumors have necrosis
and thus a comparison between PET and CT images will never match. Considering all
these facts the manual segmentation was performed on PET images. One thing that the
radiologist considered is that the images are blurred and our algorithm finds partial
volume effect corrected (PVE) functional volume (FV) which removes blur. So, all the
manual segments were drawn with the intention of removing blur and the background
around the tumor. The fixed threshold method is still used by radiologists to segment
clinical data [33, 65]. In order to provide a point of reference and objectivity, the results
from the IDTS algorithm were shown here with the T50 and T60 method. Fixed
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thresholding cannot compensate for the background activity and different signal to
background ratio which have the greatest effect on the results. The T50 and T60
consistently underestimated the FV, and overestimated the mAC because they were able
to segment pixels with very high intensity and remove the low-intensity pixels which
were part of the tumor. There have been publications where the range of threshold from
30=70 % of the maximum was used [37, 40, 66, 67], hence the T50 and T60 methods
were chosen here.
5.3.4 CONCLUSION
The segmentation results of the IDTS algorithm are very promising when
compared with manual segmentation results. There were 10 patient data sets used with a
total of 40 tumors, giving a large enough data set for comparison. The use of more
numbers of data sets would be very valuable to further test the algorithm.

5.4 PHANTOM DATA WITH DIFFERENT RECONSTRUCTION PARAMETERS
5.4.1 INTRODUCTION
The reconstruction parameters play an important role as changes in them can
affect the output of functional volume (FV) and mean activity concentration (mAC). We
tested our algorithm with changes in the number of iterations and subset of maximum
likelihood

ordered

subset

expectation

reconstruction algorithm.
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maximization

(ML-OS-EM)

iterative

5.4.2 RESULTS OF DIFFERENT RECONSTRUCTION PARAMETER
The changes of FV are shown in Figures 5.16-5.19 where the different
reconstruction parameters are used. Four reconstruction parameters are used: 8 subset × 1
iterations, 8 subset × 2 iterations, 8 subset × 8 iterations and 18 subset × 4 iterations.
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Figure 5.16 Results of FV estimation with reconstruction parameter 8 subset × 1
iterations, for different signal to background ratio (SBR) (a) 2.74 (b) 4.4 and (c) 7.3. The
FWHM of the point spread function was kept at 6 mm and matrix size 5 × 5 and the
acquisition time was 5 min.
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Figure 5.17 Results of FV estimation with reconstruction parameter 8 subset × 2
iterations, for different signal to background ratio (SBR) (a) 2.74 (b) 4.4 and (c) 7.3. The
FWHM of the point spread function was kept at 6 mm and matrix size 5 × 5 and the
acquisition time was 5 min.
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Figure 5.18 Results of FV estimation with reconstruction parameter 8 subset × 8
iterations, for different signal to background ratio (SBR) (a) 2.74 (b) 4.4 and (c) 7.3. The
FWHM of the point spread function was kept at 6 mm and matrix size 5 × 5 and the
acquisition time was 5 min.
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Figure 5.19 Results of FV estimation with reconstruction parameter 18 subset × 4
iterations, for different signal to background ratio (SBR) (a) 2.74 (b) 4.4 and (c) 7.3. The
FWHM of the point spread function was kept at 6 mm and matrix size 5 × 5 and the
acquisition time was 5 min.
In Figure 5.16 we can see that the performance of the algorithm is very poor for
0.5 ml sphere at SBR 2.74 but the performance of the algorithm improves as the sphere
size increases. Also from Figures 5.17-5.19 we see that by increasing the number of
iterations the FV estimation also improves.
In Chapter 3 we gave the details of altered histogram thresholding (HT) algorithm.
The changes were made to the HT algorithm in the iterative deconvolution thresholding

107

segmentation (IDTS) algorithm to accommodate for the possibility of heterogeneous
background in clinical data. The altered HT algorithm was re-applied on the physical
phantom data in order to determine if the FV and mAC vary greatly compared to the
results in section 5.1. The parameters in the algorithm were kept constant and the values
of the full width half maximum of the point spread function was kept at 6 mm and matrix
size of the PSF was 5 × 5, the scan time was kept at 5 min. These parameters were chosen
based on the results from section 5.1 as these parameters give the best results. In Figure
5.20 the results of FV estimation and mAC are given, where ‘% of True Volume’ and
‘Recovery Coefficient’ formula is given in Equations 5.1 and 5.2.
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Figure 5.20 FV and mAC estimation after of altered histogram thresholding (HT)
algorithm.
The algorithm was modified for clinical images but its performance was also
tested on the phantom data. We do not see much difference in FV estimation and in some
cases it is negligible.
5.4.3 DISCUSSION
The algorithm is tested by varying the parameters of the reconstruction algorithm.
Hatt et al. performed a study by changing the cameras but not changing parameters
within the camera to test the impact on the FV estimation [68]. The reconstruction
parameters usually are optimized to achieve the best images. The poor results for the
reconstruction parameter of 8 subset × 1 iterations does not affect the performance of the
algorithm as this parameter are unlikely to be set for a camera. We intended to test the
limit of how well the algorithm can perform, so reconstructing with more than one
iteration demonstrated that the algorithm performance is unaffected.
5.4.4 CONCLUSION
The iterative deconvolution thresholding segmentation (IDTS) algorithm has been
thoroughly tested on physical phantom data, simulated data and clinical data. The
robustness and reliability of the results will help building more confidence within the
radiologist.
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CHAPTER 6

Summary
6.1 OVERALL DISCUSSION AND SIGNIFICANCE OF THE WORK
The algorithm developed is unique compared to any other published algorithm
developed to date. Our algorithm accomplished tumor segmentation, volume
quantification and partial volume effect (PVE) correction. This unique feature makes the
algorithm a complete tumor quantification algorithm. As mentioned in the Chapters 2
many groups have tried to achieve tumor segmentation and PVE correction but as per our
knowledge none have achieved both together. The functional volume (FV) and mean
activity concentration (mAC) are functions of each other. Hence it is important that we
quantify both FV and mAC in the same algorithm. Both FV and mAC have been used as
prognostic indicators to predict the success of a treatment [2-6, 11-13, 25]. The mAC is
used to calculate standard uptake value (SUV); the SUV is based on mAC and is called
SUVmean. Another way to calculate SUV is by using the maximum intensity of a tumor,
which is called SUVmax. The use of maximum intensity for measuring SUV could be
risky as one pixel cannot quantify the entire tumor. If the tumors have heterogeneity then
using SUVmax would produce an incorrect result. PET images also suffer from noise, so
basing the SUV on one pixel might result in calculations using that noisy point. To avoid
the noise, another method that can be used to calculate the SUV is using peak values
(SUVpeak) which involves using some percentage of high intensity pixels so that the
problem of using one pixel is avoided.The use of mAC to calculate SUVmean is only
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possible if the images are PVE corrected.. If the images are not PVE corrected the
SUVmean would be less when compared to PVE corrected SUVmean. The SUVmean
measurement requires knowledge of the FV, where the activity of all the pixels are
summed and divided by the FV. As PVE affects both the activity within the tumor and
the activity due to blurring, FV is also affected and the error in the non PVE corrected
SUV could be doubled.
The SUV measurement of our algorithm is unique in that it accounts for tumor
activity and blur activity and divides by FV. There have been recent publications by
several groups where they account for both tumor activity and blur activity for SUV
measurement; however, they have not shown the accuracy of their FV [69, 70]. Our
algorithm demonstrated superior performance on small tumors when tested on physical
phantom data compared to any other published algorithm. The algorithm has potential to
become a “one-stop shop” for tumor quantification with capability of segmenting tumors
and measuring PVE corrected FV and mAC. The algorithm was tested with different
signal to background ratios, different levels of noise and different reconstruction
parameters. The demonstrated robustness will allow the algorithm to be applied on data
acquired from different cameras. Using one algorithm to perform analysis in multicenter
studies will give better correlation among different data sets.
Additionally, the algorithm is computationally inexpensive, making it ideal for the
analysis of a large number of data sets. The algorithm has the potential to greatly increase
the efficacy of dose calculation, and treatment planning could be adapted for every
tumor. Accuracy of our FV estimation could help reduce the toxicity among patients by
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allowing the radiologist to focus the treatment precisely within the tumor margins with
minimized damage to surrounding healthy tissues.
6.2 FUTURE WORK
The iterative deconvolution theresholding segmentation (IDTS) algorithm
developed herein is currently applied on 2D images slice by slice, once in the transverse
view and then in the coronal view. The intersection of the two volumes is considered as
the final volume. Ideally, the algorithm should be completely 3D to perform even faster
computation. The 2D application of the algorithm causes segmentation of some spurious
pixels which require further processing to be removed. The IDTS algorithm uses 256 bins
in the histogram thresholding (HT) algorithm and the final result is dependent on
choosing the number of bins. To make the algorithm more robust it has to be further
improved and if possible made independent of the choice of the number of bins used.
The graphical user interface (GUI) for the application of IDTS algorithm is still in
its developmental stage and the implementation of GUI will make the algorithm user
friendly and easy to set-up in a clinic. The volume of interest (VOI) generating algorithm
has only been applied on the liver tumor segmentation, it has to be tested on tumors from
other organs. Radiation therapy is widely used in head, neck, and prostate cancer so
segmentation of tumors in those organs should also be tested.
Furthermore, the algorithm should be tested against a simulated PET image
database [61]. Herein, the algorithm was tested on clinical data from 10 patients; one of
the future goals will be to test the algorithm on a larger patient dataset and determine if
the output from the algorithm allows to clinician to make better decisions and ultimately
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improve clinical outcomes. Thus, it would be useful to quantify tumor pre-treatment and
post-treatment and see if the functional volume (FV) and mean activity concentration
(mAC) correlates with the dose estimated.
Another place where the algorithm can potentially be used is to correct for
blurring due to respiration. Because of the fast computation of our algorithm, it can
potentially be combined with respiratory gating to provide better tumor quantification.
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